<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1606161</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The global proteome of <italic>Streptococcus pneumoniae</italic> EF3030 under nutrient-defined <italic>in vitro</italic> conditions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>De</surname>
<given-names>Supradipta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2183353/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Busch</surname>
<given-names>Larissa M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2778369/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burchhardt</surname>
<given-names>Gerhard</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1215084/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gesell Salazar</surname>
<given-names>Manuela</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2752003/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schl&#xfc;ter</surname>
<given-names>Rabea</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/617443/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steil</surname>
<given-names>Leif</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/153999/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>V&#xf6;lker</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/10390/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hammerschmidt</surname>
<given-names>Sven</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/27623/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Molecular Genetics and Infection Biology, Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Functional Genomics, Interfaculty Institute of Genetics and Functional Genomics, University Medicine</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Imaging Center of the Department of Biology, University of Greifswald</institution>, <addr-line>Greifswald</addr-line>,&#xa0;<country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: F-X Campbell-Valois, University of Ottawa, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Lance Edward Keller, University of Mississippi Medical Center, United States</p>
<p>Shaynoor Dramsi, Institut Pasteur, France</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Sven Hammerschmidt, <email xlink:href="mailto:sven.hammerschmidt@uni-greifswald.de">sven.hammerschmidt@uni-greifswald.de</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1606161</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 De, Busch, Burchhardt, Gesell Salazar, Schl&#xfc;ter, Steil, V&#xf6;lker and Hammerschmidt</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>De, Busch, Burchhardt, Gesell Salazar, Schl&#xfc;ter, Steil, V&#xf6;lker and Hammerschmidt</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>
<italic>Streptococcus pneumoniae</italic> is a human pathobiont that asymptomatically colonizes the upper respiratory tract but can cause severe diseases such as pneumonia, sepsis, and meningitis, as well as non-invasive infections like otitis media and sinusitis. It thrives in the nutrient-limited environment of the nasopharynx and has evolved mechanisms to manage host-induced stress and regulate protein levels accordingly.</p>
</sec>
<sec>
<title>Methods</title>
<p>To investigate the molecular biology of <italic>S. pneumoniae</italic> under in vitro and infection-relevant conditions, a suitable cultivation medium is essential for reproducible experiments. We, therefore optimized a chemically defined minimal medium that mimics the nutrient-limited conditions of the human nasopharynx. This medium was used to cultivate clinical isolates and other streptococcal species for proteomic analysis.</p>
</sec>
<sec>
<title>Result</title>
<p>The optimized medium enhanced growth and shortened the lag phase of <italic>S. pneumoniae</italic> and related species. Using this medium, we analyzed the global proteome of the pneumococcal colonizing strain EF3030 during its transition from early to late logarithmic growth phase. Distinct changes in protein abundance were observed in functional categories such as metabolism, amino acid synthesis, natural competence, RNA and cell wall synthesis, protein degradation, and stress responses. Notably, proteins involved in DNA uptake and processing&#x2014;such as choline-binding protein CbpD, competence factors ComGA and ComEA, and ssDNA-binding proteins Dpr and DprA&#x2014;were more abundant in the late log phase.</p>
</sec>
<sec>
<title>Discussion</title>
<p>These findings highlight dynamic proteomic changes associated with pneumococcal adaptation to nutrient-limited conditions and provide insights into the biology of strain EF3030 during colonization. The optimized medium offers a reproducible platform for studying pneumococcal physiology and pathogenesis under defined conditions.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>Streptococcus pneumoniae</italic>
</kwd>
<kwd>minimal growth medium</kwd>
<kwd>infection related condition</kwd>
<kwd>bacterial morphology</kwd>
<kwd>scanning electron microscopy</kwd>
<kwd>proteome analysis</kwd>
<kwd>competence</kwd>
</kwd-group>
<contract-num rid="cn001">DFG GRK 2719/1</contract-num>
<contract-sponsor id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content>
</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="99"/>
<page-count count="22"/>
<word-count count="10480"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Streptococcus pneumoniae</italic>, also known as pneumococcus, exhibits a range of growth behaviors, including planktonic growth as diplococci, in chains, or in biofilms. Biofilm formation is particularly significant in the asymptomatic colonization of the upper respiratory tract (URT), where <italic>S. pneumoniae</italic> predominantly resides (<xref ref-type="bibr" rid="B17">Chao et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B28">Gilley and Orihuela, 2014</xref>). However, any alteration in the URT can trigger the dissemination of pneumococci and the onset of pathogenesis (<xref ref-type="bibr" rid="B85">Simell et&#xa0;al., 2012</xref>). The ability of pneumococci to cross host tissue barriers is a critical factor in its potential to cause both non-invasive and invasive diseases such as otitis media, sinusitis, pneumonia, septicaemia, or meningitis, posing significant global health challenges (<xref ref-type="bibr" rid="B10">Bogaert et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B98">Yao and Yang, 2008</xref>; <xref ref-type="bibr" rid="B34">Hammerschmidt, 2006</xref>; <xref ref-type="bibr" rid="B14">Cartwright, 2002</xref>).</p>
<p>The growth of <italic>S. pneumoniae</italic> is significantly influenced by a diverse array of environmental and nutrient factors that can vary widely between host compartments and controlled growth conditions (<xref ref-type="bibr" rid="B35">H&#xe4;rtel et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B16">Carvalho et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B56">Leonard et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B78">Sanchez-Rosario and Johnson, 2021</xref>; <xref ref-type="bibr" rid="B13">Burghout et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B25">Fatykhova et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B80">Schulz and Hammerschmidt, 2013</xref>; <xref ref-type="bibr" rid="B36">H&#xe4;rtel et&#xa0;al., 2011</xref>). Carbohydrates and amino acids, particularly, play a decisive role in the success of the bacteria in encountering and adapting to different host niches, and in causing infectious diseases (<xref ref-type="bibr" rid="B35">H&#xe4;rtel et&#xa0;al., 2012</xref>). Within its primary niche, the URT, the availability of nutrients, including nasal transition metal levels, differs substantially from other environments such as bloodstream and lungs, which influences the phenotype and pathophysiology of pneumococci (<xref ref-type="bibr" rid="B92">van Beek et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B52">Krismer et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B19">De and Hakansson, 2023</xref>; <xref ref-type="bibr" rid="B39">Im et&#xa0;al., 2022</xref>).</p>
<p>A previous study by our group (<xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>) introduced several supplements to RPMI 1640, including uracil, adenine, glycine, choline chloride, phosphate, carbonate, and glucose, to improve the cultivation of streptococcal strains in a minimal medium. Notably, nasal fluid contains 10-fold higher concentrations of calcium and magnesium compared to iron, copper and zinc (<xref ref-type="bibr" rid="B92">van Beek et&#xa0;al., 2020</xref>). These variations in metal availability have a profound impact on <italic>S. pneumoniae</italic> growth and metabolism, for example, the balance between iron and manganese plays a key role in regulating peroxide levels via the Fenton reaction, thereby influencing the oxidative stress response and contributing to pneumococcal pathogenicity (<xref ref-type="bibr" rid="B68">Ong et&#xa0;al., 2013</xref>). Understanding host compartment-specific nutrient variations provides valuable insights into bacterial metabolism and the mechanisms that enable <italic>S. pneumoniae</italic> to adapt to different environments, thereby improving <italic>in vitro</italic> models that more accurately mimic the host environment.</p>
<p>In the nasopharynx, <italic>S. pneumoniae</italic> encounters significant challenges in overcoming mucus entrapment and evading the immune defense systems of the host. The capsular polysaccharide (CPS) helps pneumococci to bypass the electrostatic repulsion from mucus, facilitating bacterial adhesion to epithelial cells (<xref ref-type="bibr" rid="B66">Nelson et&#xa0;al., 2007</xref>). However, the capsule can also conceal key surface proteins involved in recognizing host cells. To overcome this, <italic>S. pneumoniae</italic> can undergo phase variation, switching to transparent variants that express lower capsule amounts and higher surface proteins (<xref ref-type="bibr" rid="B95">Weiser and Kapoor, 1999</xref>). Moreover, when in close contact with host cells, pneumococci reduce capsule levels, exposing adhesins that enhance interaction (<xref ref-type="bibr" rid="B34">Hammerschmidt, 2006</xref>). <italic>S. pneumoniae</italic> also employs exoglycosidases such as neuraminidase (NanA, NanB, and NanC), &#x3b2;-galactosidase (BgaA), and StrH, to modify host carbohydrate structures, thereby promoting adhesion (<xref ref-type="bibr" rid="B49">King, 2010</xref>). Recently, the concerted action of neuraminidases and pneumolysin in the destruction of the platelets was shown. Pneumococcal neuraminidases desialylate platelet glycoproteins, thereby increasing binding of pneumolysin, which finally leads to high cytotoxicity even at low toxin concentrations (<xref ref-type="bibr" rid="B27">Fritsch et&#xa0;al., 2024</xref>). Furthermore, pneumococci exploit host proteases such as plasmin, to degrade mucosal and extracellular matrix (ECM) components, facilitating stronger interactions with host cells (<xref ref-type="bibr" rid="B7">Bergmann and Hammerschmidt, 2007</xref>). Key surface adhesins including PspC, PavA, PavB, enolase, and pili allow <italic>S. pneumoniae</italic> to bind to host receptors and ECM proteins, promoting attachment and colonization (<xref ref-type="bibr" rid="B94">Weiser et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B42">Jensch et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B24">Elm et&#xa0;al., 2004</xref>). PavA and PavB target and bind to different regions of fibronectin to enhance adhesion to host cells (<xref ref-type="bibr" rid="B46">Kanwal et&#xa0;al., 2017</xref>). Lipoproteins such as PnrA, DacB, and MetQ, along with surface proteins like PspA, PspC, and PsaA, are promising candidates for vaccine development due to their role in adhesion and immune evasion (<xref ref-type="bibr" rid="B65">Narciso et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B69">Paulikat et&#xa0;al., 2024</xref>; <xref ref-type="bibr" rid="B93">Vo&#xdf; et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B50">Kohler et&#xa0;al., 2016</xref>). Additionally, the Pht proteins, especially PhtD and PhtE, are crucial for adherence and colonization, making them valuable targets for therapeutic intervention (<xref ref-type="bibr" rid="B48">Khan and Pichichero, 2012</xref>; <xref ref-type="bibr" rid="B45">Kallio et&#xa0;al., 2014</xref>).In addition to the proteins mentioned earlier, proteases and peptidases also play a crucial role in bacterial adaptation to host environments and immune evasion (<xref ref-type="bibr" rid="B60">Marquart, 2021</xref>). These enzymes enable <italic>S. pneumoniae</italic> to degrade host tissues, modulate immune responses, and survive in nutrient-limited conditions commonly encountered during infection (<xref ref-type="bibr" rid="B3">Ali et&#xa0;al., 2021b</xref>; <xref ref-type="bibr" rid="B6">Bergmann and Hammerschmidt, 2006</xref>). Proteomic analyses have identified key enzymes whose abundance fluctuates during bacterial growth, potentially influencing the bacterium&#x2019;s ability to transition between colonization and invasive phases (<xref ref-type="bibr" rid="B55">Lee et&#xa0;al., 2006</xref>). The regulation of enzyme abundances under different growth conditions, particularly during stress, highlights the significance of these enzymes in the pathophysiology of <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="B55">Lee et&#xa0;al., 2006</xref>).</p>
<p>Due to the limitations of infection-related and nutrient-defined <italic>in vitro</italic> media suitable to study the pathophysiology of pneumococci, we developed an optimized and user-friendly minimal medium in the present study. We then utilized this medium to elucidate the global proteome landscape of the non-invasive strain <italic>S. pneumoniae</italic> EF3030.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methodology</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strains and growth conditions</title>
<p>The bacterial strains used in this study (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>) were initially retrieved from glycerol stocks and cultured on blood agar plates (BA), consisting of Columbia agar supplemented with 5% sheep blood. Following this, the strains were re-streaked onto fresh BA plates and incubated for a maximum of 8-10 hours at 37&#xb0;C in the presence of 5% CO<sub>2</sub>. Bacteria from these BA plates were then used to inoculate the liquid medium.</p>
<p>To compare growth, bacterial strains were grown in RPMI-based chemically-defined medium (CDM) as established by (<xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>) to ensure reproducible growth, addressing its limitations in supporting proper growth for certain <italic>S. pneumoniae</italic> serotypes. The medium was further modified by supplementing it with methionine, iron and manganese, resulting in CDM+ (<xref ref-type="table" rid="T1">
<bold>Tables&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="table" rid="T3">
<bold>3</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Stock solutions for modified CDM medium.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Solutions</th>
<th valign="top" align="left">Components</th>
<th valign="top" align="center">Concentration [g/l]</th>
<th valign="top" align="center">Remarks</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Buffer solution</td>
<td valign="top" align="left">NaHCO<sub>3</sub>
</td>
<td valign="top" align="center">24.7</td>
<td valign="middle" rowspan="6" align="left">sterile filter and store at 4&#x2da;C</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Glycine</td>
<td valign="top" align="center">1.11</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Choline chloride</td>
<td valign="top" align="center">0.456</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">NaH<sub>2</sub>PO<sub>4</sub> &#xb7; H<sub>2</sub>O</td>
<td valign="top" align="center">3.195</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Na<sub>2</sub>HPO<sub>4</sub> &#xb7; 2H<sub>2</sub>O</td>
<td valign="top" align="center">9.22</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Glucose</td>
<td valign="top" align="center">74</td>
</tr>
<tr>
<td valign="top" align="left">Adenine/Uracil solution</td>
<td valign="top" align="left">Adenine</td>
<td valign="top" align="center">4</td>
<td valign="middle" rowspan="2" align="left">dissolve Adenine and Uracil in 40ml 1M HCl at 90&#x2da;C, then adjust the total volume with distilled water, sterile filter and store at room temp.</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Uracil</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">Iron and Manganese solution</td>
<td valign="top" align="left">MnSO<sub>4</sub> &#xb7; H<sub>2</sub>O</td>
<td valign="top" align="center">0.7</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">FeSO<sub>4</sub> &#xb7; 7H<sub>2</sub>0</td>
<td valign="top" align="center">0.625</td>
<td valign="top" align="left">dissolve in sterile distilled water and store at 4&#x2da;C</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Fe(NO<sub>3</sub>)<sub>3</sub> &#xb7; 9H<sub>2</sub>O</td>
<td valign="top" align="center">0.125</td>
<td valign="middle" align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Preparation of modified RPMI 1640-based CDM<bold>+</bold> medium.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Components</th>
<th valign="top" align="center">Volume from the stock [ml]</th>
<th valign="top" align="center">Remarks</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Buffer solution</td>
<td valign="top" align="center">40.5</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">Adenine/Uracil solution</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">re-heat the solution, stirring at 90&#x2da;C</td>
</tr>
<tr>
<td valign="top" align="center">Iron and manganese solution</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">Methionine solution (1mg/ml)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">sterile filter and store at 4&#x2da;C</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The supplements are directly added to 500ml RPMI-1640 medium with glutamine (HyClone&#x2122;, Germany). The solutions are mixed and stored at 4&#x2da;C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Difference between the CDM and CDM+ medium.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Solutions</th>
<th valign="top" align="left">Components</th>
<th valign="top" align="center">Concentration [G/L]</th>
<th valign="top" align="center">CDM</th>
<th valign="top" align="center">CDM+</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Buffer solution</td>
<td valign="top" align="left">NaHCO<sub>3</sub>
</td>
<td valign="top" align="center">24.7</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Glycine</td>
<td valign="top" align="center">1.11</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Choline chloride</td>
<td valign="top" align="center">0.456</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">NaH<sub>2</sub>PO<sub>4</sub> &#xb7; H<sub>2</sub>O</td>
<td valign="top" align="center">3.195</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Na<sub>2</sub>HPO<sub>4</sub> &#xb7; 2H<sub>2</sub>O</td>
<td valign="top" align="center">9.22</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Glucose</td>
<td valign="top" align="center">74</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">Adenine/Uracil solution</td>
<td valign="top" align="left">Adenine</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Uracil</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">&#x2713;</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">Iron and Manganese solution</td>
<td valign="top" align="left">MnSO<sub>4</sub> &#xb7; H<sub>2</sub>O</td>
<td valign="top" align="center">0.7</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">FeSO<sub>4</sub> &#xb7; 7H<sub>2</sub>0</td>
<td valign="top" align="center">0.625</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">
</td>
<td valign="top" align="left">Fe(NO<sub>3</sub>)<sub>3</sub> &#xb7; 9H<sub>2</sub>O</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="top" align="left">Methionine solution</td>
<td valign="top" align="left"/>
<td valign="top" align="center">0.0018</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">&#x2713;</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>For <italic>S. pneumoniae, S. suis, S. mutans</italic> and <italic>S. agalactiae</italic> pre-cultures were inoculated with an initial optical density (OD<sub>600nm</sub>) of 0.2 in CDM or CDM+. The strains were then sub-cultivated in fresh, pre-warmed minimal medium when they reached an optical density of 0.4, ensuring highly reproducible growth conditions during experiments. <italic>S. pyogenes</italic> was cultivated without subculturing, as the culture did not reach an optical density (OD) of 0.4. The growth of the other bacterial strains was monitored from an initial OD<sub>600nm</sub> 0.2. For electron microscopic analysis, cultivation of pneumococcal strains was done in Todd-Hewitt broth with 0.5% yeast extract (THY). The strains were inoculated at an optical density (OD<sub>600nm</sub>) of 0.08.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Field emission scanning electron microscopy (SEM) of pneumococcal strain</title>
<p>Pneumococcal strains were cultured in THY, CDM or CDM<bold>+</bold> as described above, and samples were collected at an OD<sub>600nm</sub> of 0.4 to 0.6. Bacteria were harvested by centrifugation at 3500 rpm, washed with phosphate-buffered saline (PBS), and fixed with 2.5% glutaraldehyde and 2.0% paraformaldehyde in washing buffer (0.1 M cacodylate buffer [pH 7], 0.09 M sucrose, 0.01 M CaCl<sub>2</sub>, 0.01 M MgCl<sub>2</sub>) for 1 hour at 4&#xb0;C. Following fixation, pneumococci were immobilized to poly-L-lysine-coated coverslips for 90 minutes at room temperature, and fixation continued at 4&#xb0;C overnight. The samples were then washed three times with washing buffer for 5 minutes each time, followed by treatment with 1% osmium tetroxide in washing buffer for 1 hour at room temperature. After three additional washing steps with washing buffer for 5 minutes each time, the samples were dehydrated in a graded series of aqueous ethanol solutions (10%, 30%, 50%, 70%, 90%, 100%) on ice for 15 minutes at each concentration. Prior to the final change to 100% ethanol, the samples were allowed to reach room temperature and were then critical point-dried using liquid CO<sub>2</sub>. Finally, the samples were mounted onto aluminium stubs, sputter-coated with gold/palladium, and examined with a field emission scanning electron microscope Supra 40VP (Carl Zeiss Microscopy Deutschland GmbH, Oberkochen, Germany) using the Everhart-Thornley SE detector and the inlens detector at a 80:20 ratio at an acceleration voltage of 5 kV. All micrographs were edited using Adobe Photoshop CS6 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Preparation of <italic>S. pneumoniae</italic> cellular and supernatant proteins for proteome studies</title>
<sec id="s2_3_1">
<label>2.3.1</label>
<title>Sample harvesting</title>
<p>
<italic>S. pneumoniae</italic> strain EF3030 (serotype 19F) was cultured in CDM<bold>+</bold> with sub-cultivation as described above. Pneumococci were harvested at three defined optical densities: early exponential phase (OD<sub>600</sub> 0.4), mid exponential phase (OD<sub>600</sub> 0.6), and late exponential phase (OD<sub>600</sub> 1.0). A total of 6 mL of culture was centrifuged at 3900 rpm for 10 minutes, and the supernatant was carefully collected and the tube was immediately frozen by immersion in ice-cold ethanol and maintained at -70&#xb0;C. The bacterial pellet was washed once with PBS, and the optical density was adjusted to 1.0. Subsequently, 1 mL of the bacterial suspension was centrifuged again at 3900 rpm for 5 minutes, and the resulting bacterial pellet was stored at -70&#xb0;C until sample preparation.</p>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>Sample preparation</title>
<p>The collected samples of bacterial pellets were each resuspended in 50 &#xb5;L of 20 mM HEPES buffer (pH 8) containing 1% SDS. Cell disruption was achieved through mechanical disruption using a bead mill at 3000 rpm for 3 minutes in liquid nitrogen. The resulting frozen powder was then dissolved in 150 &#xb5;L of 20 mM HEPES buffer (pH 8) with 1% SDS. The solution was subjected to shaking at 1400 rpm at 95&#xb0;C for 1 minute. After cooling, Pierce&#x2122; Universal Nuclease (Pierce, Thermo Fisher Scientific, MA, United States; 2.5 U, 4 mM MgCl2) was added, followed by an incubation in an ultrasonic bath for 5 minutes. Thereafter, all samples were centrifuged at 17000 g for 30 minutes, and the supernatant was carefully collected for subsequent analysis by mass spectrometry.</p>
<p>Proteins from the supernatant were precipitated using trichloroacetic acid (TCA). A volume of 1.5 mL of the supernatant was mixed with 225 &#xb5;L of 100% TCA, resulting in a final concentration of 15% TCA. The solution was thoroughly mixed and incubated at 4&#xb0;C for 48 hours. Following incubation, the solution was centrifuged at 17,000 g for 60 minutes at 4&#xb0;C. The supernatant was carefully discarded, and the pellet was washed with 70% ice-cold ethanol by centrifugation at 17,000 g for 10 minutes at 4&#xb0;C. This wash procedure was repeated three times with decreasing volumes of ethanol: 500 &#xb5;L wash 1), 200 &#xb5;L (wash 2), 180 &#xb5;L (wash 3). After the final washing step, the ethanol was removed and the pellet containing the proteins was air-dried. The proteins were then resuspended in 15 &#xb5;L of 20 mM HEPES buffer (pH 8) containing 1% SDS to solubilize the membrane proteins and incubated at 65&#xb0;C for 2 minutes. Protein concentrations of protein samples were determined using the Thermo Micro BCA Kit employing the BCA assay analysis pipeline included in the MassSpecPreppy pipeline (<xref ref-type="bibr" rid="B76">Reder et&#xa0;al., 2024</xref>). Tryptic digestion of the pellet and supernatant-derived proteins was performed using the SP3 protocol (<xref ref-type="bibr" rid="B76">Reder et&#xa0;al., 2024</xref>). The resulting peptides were analyzed by mass spectrometry on an Orbitrap Exploris&#x2122; 480 mass spectrometer (Thermo Fisher Scientific), coupled to an Ultimate 3000 nano-LC system (Thermo Fisher Scientific). A data-independent acquisition (DIA) mode was utilized to acquire the data, for specific details see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables S3</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>S4</bold>
</xref>. Data are available at ProteomeXchange consortium (<xref ref-type="bibr" rid="B21">Deutsch et&#xa0;al., 2023</xref>) via PRIDE repository with identifier PXD062379 (<xref ref-type="bibr" rid="B71">Perez-Riverol et&#xa0;al., 2024</xref>, <xref ref-type="bibr" rid="B72">2016</xref>).</p>
</sec>
<sec id="s2_3_3">
<label>2.3.3</label>
<title>Data analysis</title>
<p>The mass spectrometric data were analyzed using the SpectronautTM Software (v19.1), via a spectral library-based approach. The search against a protein sequences database of <italic>S. pneumoniae</italic> EF3030 (NCBI RefSeq accession no. NZ_CP035897.1, alternatively: NZ_CP035897) included tryptic peptides with up to two missed cleavages, fixed carbamidomethylation of cysteine and oxidation of methionine and N-terminal acetylation as variable modifications. Further analysis was performed using R version 4.4.1 and the SpectroPipeR package 0.3.0 (<xref ref-type="bibr" rid="B62">Michalik et&#xa0;al., 2025</xref>). The PneumoWiki (<ext-link ext-link-type="uri" xlink:href="https://pneumowiki.med.uni-greifswald.de">https://pneumowiki.med.uni-greifswald.de</ext-link>) annotations and descriptions of <italic>S. pneumoniae</italic> EF3030 proteins were used to analyze the genome&#x2019;s functional response to the minimal medium.</p>
<p>For comparative analysis of protein composition between the cellular and supernatant fractions, intensity-based absolute quantification (iBAQ) values were calculated using Spectronaut. The relative iBAQ values were expressed as a percentage of the total sum of iBAQ values for each sample condition (<xref ref-type="bibr" rid="B81">Schwanh&#xe4;usser et&#xa0;al., 2011</xref>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3</bold>
</xref>). Protein localization were predicted using DeepLocPro v1.0 (<xref ref-type="bibr" rid="B63">Moreno et&#xa0;al., 2024</xref>) with &#x2018;&#x2212;&#x2212;group positive&#x2019; Gene set enrichment analyses (GSEA; <xref ref-type="bibr" rid="B88">Subramanian et&#xa0;al., 2005</xref>) was performed using the fast gene set enrichment analysis (fgsea) R-package (<xref ref-type="bibr" rid="B51">Korotkevich et&#xa0;al., 2016</xref>), leveraging TIGRFAM (<xref ref-type="bibr" rid="B32">Haft et&#xa0;al., 2013</xref>) functional annotations of <italic>S. pneumoniae</italic> EF3030 proteins as retrieved from PneumoWiki and integrating orthologously mapped RegPrecise (<xref ref-type="bibr" rid="B67">Novichkov et&#xa0;al., 2013</xref>) based regulon information of <italic>S. pneumoniae</italic> TIGR4 (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). Hierarchical clustering of protein profiles of proteins identified with at least two peptides in both fractions was performed in R using the hclust function (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Table S3</bold>
</xref>). As distance metric, spearman correlation was applied, and 1-r was used. For distance determination between clusters, the average method was used. Clusters cutting height was set to 40% of the maximal distance. Functional characterization of the clusters was performed by over representation analysis using the Fisher&#x2019;s Exact test and employing TIGRFAM functional annotation and regulon information.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Methionine and the trace elements, iron and manganese enhanced streptococcal fitness and growth in minimal medium</title>
<p>Previous studies have shown that amino acids are essential for improved growth behavior in minimal medium for the cultivation of <italic>S. pneumoniae</italic>, serotype 2, D39 (<xref ref-type="bibr" rid="B35">H&#xe4;rtel et&#xa0;al., 2012</xref>). Later a RPMI based chemical-defined minimal medium was established with supplementation of uracil-adenine solution (CDM) (<xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>). However, <italic>S. pneumoniae</italic> EF3030, serotype 19F, and TIGR4, serotype 4, exhibited a prolonged lag phase and a lower yield in this medium (<xref ref-type="bibr" rid="B2">Ali et&#xa0;al., 2021a</xref>). To further improve the growth conditions and ensure reproducibility of pneumococcal growth, we supplemented CDM with methionine as well as with the metal ions, iron and manganese, which are needed as trace elements for bacterial growth. This newly developed minimal medium (CDM<bold>+</bold>) significantly reduced the lag phase of the strain EF3030. Similarly, growth of the other laboratory strains TIGR4, D39 and capsule knockout strains, D39&#x394;<italic>cps</italic> and TIGR4&#x394;<italic>cps</italic> was enhanced in CDM<bold>+</bold> (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>). Furthermore, we cultivated pneumococcal clinical isolates of serotype 8, 12F, or 22F in CDM<bold>+</bold> and monitored their growth. Indeed, a shorter lag phase and accelerated growth were observed for all strains (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C, D</bold>
</xref>). To assess growth of other pneumococcal strains in CDM+, we tested a larger panel of invasive clinical isolates covering some of the serotypes included in the PPSV-23 vaccine (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S4</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>). To test whether this medium is also suitable for cultivating other streptococcal species, we tested a panel of streptococcus species that are not only phylogenetically and physiologically diverse, but also clinically and scientifically significant. We cultivated <italic>S. mutans, S. suis</italic>, <italic>S. pyogenes</italic> (GAS) and <italic>S. agalactiae</italic> (GBS) in CDM<bold>+</bold> (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E, F</bold>
</xref>). However, <italic>S. mutans</italic> and <italic>S. suis</italic> strains showed similar growth in both media, CDM and CDM<bold>+</bold> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Remarkably, <italic>S. pyogenes</italic> showed no real growth in both media but also no death phase, suggesting that this fastidious organism has more stringent growth requirements and may require additional components for growth in a minimal medium. In contrast, <italic>S. agalactiae</italic> grew to higher optical density in CDM<bold>+</bold> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). Since this medium supports growth of clinically and biologically important streptococci and pneumococci, we conclude that the improved minimal medium CDM<bold>+</bold> can be applied to study the (patho-)physiology of different streptococcal species under reliable growth conditions.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Optimization of a minimal medium for growth of pneumococcal and other streptococcal species. To establish a reliable and reproducible growth medium for pneumococcal and other streptococcal species, we compared the growth of these bacteria in two different media. Bacteria were cultured in RPMI supplemented with adenine and uracil (CDM), represented by the dotted lines, and in RPMI supplemented with adenine, uracil, methionine, iron, and manganese (CDM+), represented by the bold lines. The standard deviation (SD) of the measurements is represented by the shadow, indicating the variability of the results across three independent replicates (n=3). <bold>(A)</bold> Growth of pneumococcal strains, serotype 19F (EF3030), serotype 2 (D39) and serotype 4 (TIGR4). <bold>(B)</bold> Nonencapsulated mutants: D39&#x394;<italic>cps</italic> and TIGR4&#x394;<italic>cps.</italic> <bold>(C)</bold> Invasive clinical isolates of <italic>S. pneumoniae</italic>: serotype 8. <bold>(D)</bold> Invasive clinical isolates of <italic>S. pneumoniae</italic>: 12F and 22F. <bold>(E)</bold> <italic>S. mutants</italic> and <italic>S. suis.</italic> <bold>(F)</bold> Group A streptococcal strain, <italic>S. pyogenes</italic> and Group B strain, <italic>S. agalactiae</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Morphological characteristics of pneumococci in the exponential growth phase</title>
<p>Three encapsulated pneumococcal strains (D39, TIGR4, and EF3030) of different serotypes (2, 4, and 19F respectively) along with the isogenic non-encapsulated mutants (TIGR4&#x394;<italic>cps</italic> and D39&#x394;<italic>cps</italic>) were cultivated in three different media: the complex medium THY, as well as the minimal media CDM and CDM<bold>+</bold>. Pneumococci were harvested in exponential growth phase at an optical density of (OD<sub>600nm</sub>) 0.6 and prepared for scanning electron microscopy to visualize and illustrate the organization and morphology of the pneumococcal strains at high resolution. The encapsulated strains EF3030, TIGR4, and D39 formed aggregates in CDM<bold>+</bold>, whereas they did not form these assemblages when cultivated in either CDM or THY (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>), suggesting that the bacterial aggregates are due to the supplements present in CDM<bold>+</bold>. In contrast to wild-type pneumococci, the isogenic non-encapsulated strains TIGR4&#x394;<italic>cps</italic> and D39&#x394;<italic>cps</italic> appear smooth due to the lack of capsule and did not form substantial aggregates even in CDM<bold>+</bold>, suggesting an impact of the capsular polysaccharide (CPS) on pneumococcal aggregation. Notably, the encapsulated wild-type pneumococci were also surrounded by some vesicle-like structures that provided a rough texture to the bacterial surface, which was predominantly visible in CDM<bold>+</bold> and appeared to contribute to aggregation (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>). Furthermore, serotype 4 strain TIGR4, which is an invasive clinical isolate, formed longer chains in the complex THY medium compared to the minimal media. TIGR4 wild-type strain also displayed pili-like structures on the surface and mostly near the septum region.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Scanning electron micrographs of <italic>S. pneumoniae</italic> cultivated in THY, CDM, or CDM<bold>+</bold>. EF3030 (serotype 19F), D39 (serotype 2), TIGR4 (serotype 4), D39&#x394;<italic>cps</italic> and TIGR4&#x394;<italic>cps</italic> were cultured at 37&#x2da;C up to an optical density of OD<sub>600nm</sub> 0.6 in each medium. Pneumococci were harvested and subjected to scanning electron microscopy. The micrographs were taken at a magnification of 10,000x and the inset micrographs in the top right corner were taken at a higher magnification of 30,000x. These higher magnifications provide more detail of the pneumococcal surface structures and aggregates. Scale bars = 1 &#xb5;m; Scales bars of the inset micrographs = 300 nm (see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g002.tif"/>
</fig>
<p>To validate the growth differences observed between CDM and CDM+ media, we further determined the number of viable bacteria (CFU/mL) at defined time points during growth. As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S5</bold>
</xref> (Panel B), <italic>S. pneumoniae</italic> EF3030 was assessed at early, mid and late exponential phases. The CFU data confirmed that the elevated OD<sub>600</sub> obtained in CDM+ medium correspond to a higher number of viable cells, supporting the conclusion that CDM+ enhances bacterial proliferation. However, in CDM, EF3030 did not grow beyond OD<sub>600</sub> 0.5. We acknowledge that OD<sub>600</sub> readings can be affected by e.g., cell aggregation, however, the CFU data demonstrated that the increased optical density correlated with bacterial growth. In addition, growth curve analysis of the TIGR4&#x394;<italic>cps</italic> strain (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S5</bold>
</xref>, Panel A) showed that CDM+ not only leads to a higher bacterial density but also improves growth kinetics by reducing the lag phase and increasing the growth rate. This is in contrast to its slower growth in CDM, further emphasizing the advantages of CDM+ medium. These findings substantiate our conclusion that the optimized CDM+ medium promotes enhanced and more robust growth of pneumococcal strains under nutrient-defined conditions.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Global proteome analysis of <italic>S. pneumoniae</italic> EF3030, serotype 19F</title>
<p>To elucidate the physiological profile of <italic>S. pneumoniae</italic> strain EF3030 at protein level when cultured in the minimal medium CDM+, we conducted a comprehensive proteomic analysis of both the cellular and the supernatant fractions. Although the genome of serotype 19F strain, EF3030 has been published (<xref ref-type="bibr" rid="B44">Junges et&#xa0;al., 2019</xref>), a detailed proteome profile is not yet available for this strain nor for any other serotype 19F strain. Our goal was to characterize the protein composition of <italic>S. pneumoniae</italic> strain EF3030 across different growth phases (early exponential, mid-exponential, and late exponential phases) using mass spectrometry.</p>
<sec id="s3_3_1">
<label>3.3.1</label>
<title>Experimental setup and protein identification</title>
<p>
<italic>S. pneumoniae</italic> EF3030 was cultured in CDM<bold>+</bold> and harvested at three growth phases, defined by optical density (OD<sub>600nm</sub>) values of 0.4 (early exp), 0.6 (mid-exp), and 1.0 (late exp) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Total protein was isolated from both the cytosolic and supernatant fractions and proteome analysis was performed using the PneumoWiki annotated genome of strain EF3030. NZ_CP035897.1 predicts 1862 protein-coding genes, we were able to successfully identify 1381 proteins in the cytosolic fraction and 1373 proteins in the supernatant fraction, with more than two peptides with ion q-values less than 0.001 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). These numbers represent 74.16% and 73.73% of the annotated theoretical proteome in the cytosolic and supernatant fractions, respectively. The high number of different proteins in the supernatant indicated partial cell lysis already at an early stage. A comparison revealed 1,344 proteins common to both fractions, with 37 and 29 proteins uniquely identified in the cytosol and supernatant, respectively (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Identification of pneumococcal proteins exclusively detected in the cytosol or supernatant fractions. <bold>(A)</bold> Sampling of bacterial cultures and their corresponding supernatants were done at different exponential growth phases &#x2014;early (OD<sub>600</sub> = 0.4, green), mid (OD<sub>600</sub> = 0.6, red), and late (OD<sub>600</sub> = 1.0, blue). The three lines represent the biological replicates. <bold>(B)</bold> A total of 1,381 proteins were identified in the cytoplasm and 1,373 proteins were identified in the supernatant, with two or more than two peptides analyzed by mass spectrometry. Of these, 37 proteins were exclusively found in the cytosol, whereas 29 proteins were uniquely present in the supernatant, as depicted in the Venn diagram. <bold>(C)</bold> Abundance of the proteins detected exclusively in the cytosol and the supernatant. Heatmaps represent the signal log ratio comparisons during early, mid and late exponential growth phases. &#x3a6; indicates significant values, p-value less than 0.05. * Indicates absolute fold change greater than or equal to 1.5. The protein EF3030_RS00105 is in &#x2018;brackets&#x2019; because the identified peptides could originate from other annotated proteins.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g003.tif"/>
</fig>
</sec>
<sec id="s3_3_2">
<label>3.3.2</label>
<title>Proteins identified in the cytosolic fraction</title>
<p>In the cytosolic fraction, 37 proteins were uniquely identified (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), including key stress response and growth-regulatory proteins. ComEC, which is involved in DNA internalization related to competence and PtvR, important for fitness coping with antibiotic and stress, were detected in the cytosol (<xref ref-type="bibr" rid="B74">Pimentel and Zhang, 2018</xref>; <xref ref-type="bibr" rid="B57">Liu et&#xa0;al., 2017</xref>). Notably, the toxin-antitoxin system components YefM, RelE1, and HicB, which are implicated in bacterial persistence, were identified in this fraction only. Bacterial persistence is a crucial factor in the survival of <italic>S. pneumoniae</italic> within the host and during antibiotic treatment. HicB was of particular interest, as it exhibited a 1.7-fold increase during the mid-exponential phase and 1.5-fold during the late exponential phase (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Table S1</bold>
</xref>).</p>
</sec>
<sec id="s3_3_3">
<label>3.3.3</label>
<title>Proteins identified in the supernatant fraction</title>
<p>The supernatant fraction contained 29 unique proteins (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Table S2</bold>
</xref>). Most of these proteins were truly secreted or surface associated, including CbpF, ComGC, ComB, ComEA, NanB, EndoD, MtsC, QueT, CpsI, and EabC (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). However, we also detected some cytoplasmic proteins such as Mga2, a virulence factor transcriptional regulator, together with Paal, and YbhL, mainly due to a substantial lysis rate. Notably, a significant proportion of the detected proteins in the supernatant fraction contribute directly or indirectly to virulence, including NanB, CpsI, ComEA and EndoD. These proteins exhibited distinct abundance patterns during growth, with EndoD and ComEA increasing in later growth phases, whereas CpsI showed a decrease in abundance under the same conditions. Furthermore, EabC, associated with a domain that could be linked to host interaction and the competence factor ComB displayed significant increases in abundance during the late exponential phase. The choline-binding protein CbpF also displayed a notable 3.2-fold increase during the late log phase. The surface proteins, including CpsI and ComEA, demonstrated phase-dependent abundance fluctuations, reflecting the adaptive response of <italic>S. pneumoniae</italic> to changing growth conditions.</p>
</sec>
<sec id="s3_3_4">
<label>3.3.4</label>
<title>Protein composition comparison: cytosol vs. supernatant</title>
<p>The comparative analysis of the relative iBAQ values for cytosolic proteins and proteins present in the supernatant revealed a wide range of protein abundances, spanning approximately 6 log10 steps (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3A</bold>
</xref>). Highly abundant proteins, including Gap (GAPDH), Tuf, enolase (Eno), EF3030_RS05545 (PtsH), EF3030_RS02365 (Pgk) and ribosomal proteins (e.g., RplX), were found in both fractions. Notably, when the total proteins detected in the late exponential phase were analyzed, LytN and SpxB were found among the top 10 highest abundant proteins. LytN, a murein hydrolase, plays a crucial role in cell division and cell wall integrity. Overexpression of LytN has been shown to cause cell lysis in other bacteria like <italic>S. aureus</italic> (<xref ref-type="bibr" rid="B26">Frankel et&#xa0;al., 2011</xref>). SpxB, a pyruvate oxidase, is key enzyme for H<sub>2</sub>O<sub>2</sub> production (<xref ref-type="bibr" rid="B5">B&#xe4;ttig and M&#xfc;hlemann, 2008</xref>). The protein composition in the supernatant fraction in general mirrored that of the cytosolic profile (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3B</bold>
</xref>). Proteins that were at least 100-fold enriched in the supernatant fraction, including those involved in cell surface attachment and extracellular functions, such as PfbA, ZmpD, ZmpB, MapP, EF3030_RS10100, EF3030_RS00555, and PcsB. Conversely, we identified the ribosomal protein RpmC, EF3030_RS06250 (AroH), EF3030_RS02670, EF3030_RS02470, and EF3030_RS10365 as being at least 20-fold enriched in the cytosolic fraction.</p>
<p>
<italic>In silico</italic> predictions of protein localization by DeepLocPro (<xref ref-type="bibr" rid="B63">Moreno et&#xa0;al., 2024</xref>) indicate that the supernatant fraction is substantially enriched in extracellular proteins and cell wall and surface proteins across all analyzed growth states (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Notably, the relative abundance of membrane and cytoplasmic proteins does not differ between the two fractions, a finding that is consistent with the high frequency of lysis of pneumococcal cells (<xref ref-type="bibr" rid="B91">Terrasse et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B23">Eldholm et&#xa0;al., 2009</xref>)</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Comparison of the abundance of proteins regarding their predicted localization by DeepLocPro (<xref ref-type="bibr" rid="B63">Moreno et&#xa0;al., 2024</xref>). The violin plot shows log10-transformed relative iBAQ values. Medians are indicated as lines. Significant differences of mean relative abundances between the cellular and supernatant (secretome) fraction was tested using a Wilcoxon-test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g004.tif"/>
</fig>
</sec>
<sec id="s3_3_5">
<label>3.3.5</label>
<title>Growth-dependent changes of the cellular proteome and of the exoproteome</title>
<p>To investigate pneumococcal physiology in the newly developed minimal medium CDM<bold>+</bold>, pneumococcal cells and supernatants were collected at early, mid, and late exponential growth phases as shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. Comparative analysis of the mid and late exponential phase samples versus early exponential phase samples allowed for the examination of changes in protein expression profiles, metabolic alterations, and bacterial cell adaptations across varying growth states and cell densities (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). This information is crucial for the development of therapeutics targeting bacterial proteins, as it can provide insight into strategies to inhibit bacterial growth and progression of infection at different stages. The distinct growth phases correspond to different numbers of bacteria during colonization or dissemination in the blood or cerebrospinal fluid. Initially low bacterial number initiate adherence or cross host barriers and subsequent accumulation or biofilm formation contribute to the progression of infection (<xref ref-type="bibr" rid="B33">Hall-Stoodley et&#xa0;al., 2004</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Analysis of protein profile clusters. For clustering the log2 protein intensity ratios compared to OD<sub>600nm</sub> 0.4 were used for the supernatant and cellular fraction. Line plots of protein profiles for each cluster are shown, with cellular fraction profiles are depicted in blue and supernatant fraction profiles in red. To show the general cluster profile the LOESS-fit of all protein profiles are depicted as solid line (<xref ref-type="bibr" rid="B41">Jacoby, 2000</xref>). The total number of proteins in each cluster is indicated at the top of each cluster panel. Each cluster was tested for over-representation of proteins belonging to known regulons and known TIGRFAM functional annotations according to PneumoWiki (<ext-link ext-link-type="uri" xlink:href="https://pneumowiki.med.uni-greifswald.de">https://pneumowiki.med.uni-greifswald.de</ext-link>). Over-representation was assessed using one-sided Fisher&#x2019;s exact test (p-value &#x2264; 0.05). Over-represented regulons and functional categories are depicted in the left box and right box, respectively, along with their corresponding p-values in brackets.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g005.tif"/>
</fig>
<p>To gain a general overview about the protein abundance changes along the growth states, the obtained proteome profiles of <italic>S. pneumoniae</italic> EF3030 were normalized to the protein abundance at the early exponential phase and then clustered. Hierarchical clustering was applied (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Table S3</bold>
</xref> for the data) and clusters were defined by cutting of 40% of the total tree distance. This resulted in eight general protein clusters representing the proteome dynamics along the growth states in the supernatant and cytoplasmic fraction (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Clusters C1 and C6 represent proteins associated with metabolic functions as identified using overrepresentation analysis of known regulons and functional TIGRFAM categories. Of note, proteins belonging to the fatty acid biosynthesis FabT regulon and the purine synthesis PurR regulon as well as amino acid biosynthesis proteins tend to accumulate along the growth state in the cytoplasmic and supernatant fraction, whereas proteins belonging to the central sugar metabolism CcpA regulon, the maltose utilization MalR regulon, sialic acid utilization NanR and RpiR regulons, fructooligosaccharides utilization RbsR regulon and the trehalose utilization TreR regulon decreased in abundance in the cytosolic and supernatant fraction during progression through growth phases (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). In that sense, our data reveal a shift from sugar-based glycolysis to other metabolic aspects over time when growth in the newly optimized medium and metabolic dynamics also shape the pathophysiological potential of pneumococci. In general, the CcpA regulated central metabolism is closely linked to virulence (<xref ref-type="bibr" rid="B40">Iyer et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B15">Carvalho et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B99">Zhang et&#xa0;al., 2023</xref>) and CodY-driven metabolic aspects are essential in colonization and infection processes of pneumococci (<xref ref-type="bibr" rid="B38">Hendriksen et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B43">Johnston et&#xa0;al., 2015</xref>). Proteins of the clusters C3 and C5 could be quantified in higher abundance in the later phases of growth in the supernatant. These clusters comprised of the zinc acquisition regulator AdcR, manganese homeostasis MntR regulon, the N-acetylglucosamine utilization and the hyaluronate utilization, RegR regulon as well as protein&#x2019;s function associated to the cell envelope, demonstrating the need of metal ions and accumulation of classic extracellular proteins during later growth phases. Proteins of the DNA metabolism, protein biosynthesis (cluster C4) and biosynthesis of cofactors (cluster C8) remained relatively stable during the exponential growth phase, highlighting their essential role in the bacterial physiology.</p>
<p>To gain detailed insights into the growth state dependent changes in protein levels in both the cytosolic and supernatant fraction, pairwise comparisons were performed for the samples harvested in the late exponential phase to samples harvested in early exponential phase using the ROPECA approach (<xref ref-type="bibr" rid="B89">Suomi and Elo, 2017</xref>) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Tables S1</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>S2</bold>
</xref>). Only proteins with an absolute fold change of 1.5-fold or greater and an adjusted p-value less than 0.05 were considered as significantly altered and were analyzed (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4</bold>
</xref>). 34 proteins showed increased abundance in both fractions, the cytosol and supernatant. In contrast, 65 proteins were significantly lower in abundance in the cytosol fraction and 11 proteins were significantly lower in the supernatant fraction (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). We then classified these differentially expressed proteins into functional groups of interest: transporter proteins (29 in cytosol and 10 in supernatant), gene regulation proteins (7 in cytosol and 1 identified in supernatant), metabolic proteins (31 in cytosol and 6 in supernatant), virulence and competence factors (9 in cytosol and 15 in supernatant), proteins with others functions (11 in cytosol and 10 in supernatant) and proteins of unknown function (7 in cytosol and 5 in supernatant) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). Detailed description along with the fold change is shown in the <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables S4A, B</bold>
</xref>.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Quantification of the abundant proteins in the cytosol and the supernatant fractions during exponential growth. <bold>(A)</bold> Significant changes in protein abundance during the late exponential phase compared to the early exponential phase are visualized using volcano plots. The data represents the significant signal log ratio comparison between the different optical densities, with p-value less than 0.05 and a fold change greater than 1.5-fold. Proteins with higher abundance are labelled red, whereas proteins with a decrease in protein abundance are marked in blue. <bold>(B)</bold> Pie charts illustrate the significantly abundant proteins and their functions in the cytosol and supernatant during the exponential growth phase. Arrows indicate an increase or a decrease in protein abundance by comparing late log to early exponential phase. <bold>(C)</bold> A selection of proteins with increased abundance in the cytosol or supernatant, as well as proteins with reduced abundance in the cytosol or supernatant, at late growth.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g006.tif"/>
</fig>
<p>To determine the overlap of the proteins shown in the volcano plot (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>) in both the cytosolic and the supernatant fraction, a Venn diagram (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>) was used. Sixteen proteins (the Pht family proteins, the Adc system proteins involved in Zinc homeostasis, ComGA, sortase SrtA, YdcP_2, BguA, Mip, Nfr1, Nfr2) were found to significantly increased in both the cytosol and the supernatant, while three proteins (FruA, TreP and GadW) were significantly reduced in both fractions (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables S4A, B</bold>
</xref>, proteins marked with &#x201c;*&#x201d;).</p>
</sec>
<sec id="s3_3_6">
<label>3.3.6</label>
<title>Transporters</title>
<p>During the late-log phase (OD<sub>600</sub> 1.0), increased abundance of various transporter proteins was measured in both the cytosolic and supernatant fractions (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). Notably, PTS and ABC transporters involved in sugar uptake, such as BguB, BguC, and BguD, were more abundant in the cytosol. Moreover, zinc and metal transporters, such as AdcA, AdcAII, AdcC, and CtpA, were elevated in both fractions, indicating the bacterial adaptation to metal ion availability during growth, as indicated by overrepresentation of the AdcR regulon in cluster C3 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). In contrast, several sugar transporters, including MalC, BrnQ, GadW, FruA, and TreP exhibited reduced abundance during the late-exponential phase (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4B</bold>
</xref>). This is in line with the observation that the general sugar metabolism decreases in later growth states (cluster C6; <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
</sec>
<sec id="s3_3_7">
<label>3.3.7</label>
<title>Gene regulators</title>
<p>Several transcriptional regulators, including the Zn-dependent regulator AdcR showed increased abundance in both the cytosolic fraction and the supernatant fraction during the late-exponential phase (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). Other regulators like GntR and CopY were significantly increased in the cytosolic fraction during the later growth phase (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Table S1</bold>
</xref>). In contrast, other regulators such as NmlR and FruR, exhibited a significant reduction in the cytosol and were also reduced in the supernatant during later growth phases suggesting growth-phase-specific regulation of bacterial adaptation and stress response (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Excel Tables S1, S2</bold>
</xref>).</p>
</sec>
<sec id="s3_3_8">
<label>3.3.8</label>
<title>Metabolic proteins</title>
<p>Metabolic proteins involved in amino acid and sugar metabolism, such as galactokinase (GalK), LacG, and arginine deaminase system (ArcA, ArgF (ArcB), ArcC), exhibited decreased abundance during the late-log phase in the cytosol (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4B</bold>
</xref>). In contrast, some metabolic enzymes, including GuaA2, PEP phosphomutase, YdpC_2, and BguA, showed increased abundance in the cytosol, indicating changes in metabolic activity during different growth phases (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). This metabolic adaptation is also reflected by the identification of the two general metabolic clusters C1 and C6 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). In general, sugar metabolism proteins tend to decrease during the late exponential phase in both the cytosolic and supernatant fractions, whereas the abundance of proteins involved in amino acid and purine and pyrimidine biosynthesis increased.</p>
<p>This shift in metabolic regulation is further supported by gene set enrichment analysis (GSEA), as depicted in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>. The plot illustrates functional annotation and regulon-based enrichment across different growth phases (OD 0.6/0.4 and OD 1.0/0.4). The color of the dots represents the direction of normalized enrichment scores (NES), with red indicating positive enrichment and blue indicating negative enrichment. The size of each dot corresponds to the absolute NES value, highlighting the magnitude of enrichment. Notably, during the transition from mid to late exponential phase, cellular processes and nucleotide metabolism were positively enriched, while energy metabolism showed a negative enrichment. Additionally, the CcpA regulon, known for its role in carbon metabolism, exhibited significant negative enrichment, reinforcing the observed decline in sugar metabolism proteins (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). These findings collectively suggest a metabolic shift favoring nucleotide and amino acid biosynthesis over sugar metabolism during later growth stages.</p>
</sec>
<sec id="s3_3_9">
<label>3.3.9</label>
<title>Competence and Other proteins</title>
<p>Remarkably, we observed a more than 2-fold increase of the competence type IV pilus ATPase ComGA in both pneumococcal fractions during the late exponential phase (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). In addition, ComB, a component of the competence system, was found to be 6.1-fold increase in the supernatant at the late exponential phase (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). Competence requires a complex and well-timed interplay of several regulons (such as ComE, ComX, BlpR) (<xref ref-type="bibr" rid="B97">Winkler and Morrison, 2019</xref>; <xref ref-type="bibr" rid="B96">Weyder et&#xa0;al., 2018</xref>) We found that the ComX1 regulon has a general peak in the mid exponential phase while protein levels decrease in the supernatant fraction during the late exponential phase (cluster C7; <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>)</p>
<p>Additionally, several cytoplasmic proteins involved in DNA processing and repair showed increased abundance over time (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). The single-strand DNA-binding protein, SsbB (EF3030_RS09295) stabilizes single-stranded DNA during replication, recombination, and repair. DprA facilitates natural transformation by binding and guiding incoming DNA into the chromosome. Sortase A, although primarily responsible for anchoring surface proteins, may support competence by attaching transformation-related proteins to the cell surface. SsbB and DprA are directly involved in DNA uptake and processing during natural transformation, a process that enhances genetic adaptability. Sortase A might contribute to this process by supporting the display of competence-associated factors on the cell surface. In the supernatant fraction, bacteriocin (EF3030_RS00555) or bacteriocin-like protein BlpU, bacteriocin secretion accessory protein (EF3030_RS02515), serine hydrolase (EF3030_RS00045), a glycoside hydrolase (EF3030_RS10670), and a surface protein (EF3030_RS05660) increased significantly at late exponential phase (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). The secreted proteins (bacteriocins, hydrolases, and surface proteins) indicate enhanced bacterial competition, environmental adaptation, and potential host interactions. In contrast, out of the 11 significantly reduced proteins in the supernatant (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>), 8 proteins were exclusively found in the supernatant including YqeH, RsgA, ParB partition protein, methyltransferase domain containing protein, and the DEAD box helicase, whereas 3 were also found in the cytosol (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4B</bold>
</xref>).</p>
</sec>
<sec id="s3_3_10">
<label>3.3.10</label>
<title>Protein profiles of surface proteins and proteases - investigation of the repertoire of selected virulence factors</title>
<p>For comparative analysis, we classified various proteins based on their surface anchoring mechanisms (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>) (<xref ref-type="bibr" rid="B53">Lane et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B6">Bergmann and Hammerschmidt, 2006</xref>; <xref ref-type="bibr" rid="B70">P&#xe9;rez-Dorado et&#xa0;al., 2012</xref>). The data revealed a significant increase in the signal log ratio of several lipoproteins, choline-binding proteins, sortase-anchored proteins, and non-classical surface proteins (NCSP) in both the cytosolic and supernatant fractions comparing the mid and late log phase to the early log phase (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Excel Tables S1, S2</bold>
</xref>). Choline-binding proteins were detected in both the cytoplasmic and supernatant fractions, with the most striking increase observed for the murein hydrolase CbpD, which exhibited a 54.7-fold increase in abundance in the supernatant during the late log phase (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). A 3.2-fold increase in abundance was also detected for CbpF, which was exclusively found in the supernatant (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). In contrast, while all choline-binding proteins were present in the cytoplasmic fraction at low levels, their abundance remained relatively unchanged throughout growth. We observed PhtD to be the most significantly elevated protein detected in both the cytoplasmic and supernatant fractions during the later stages of log growth (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). PhtD and PhtE are members of the histidine triad protein (Pht) family, characterized by four to six histidine motifs that bind divalent metal cations, such as Zn<sup>2+</sup> (<xref ref-type="bibr" rid="B8">Bersch et&#xa0;al., 2013</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Heat maps of surface associated proteins with two or more peptides identified both in the cytosol and the supernatant of strain EF3030 by mass spectrometry analysis. The abundance of detected proteins was classified as choline-binding proteins (CBP), lipoproteins, sortase-anchored proteins and non-classical surface proteins (NCSP) in the cytosol and supernatant. The heat map represents the signal log ratio values between mid-exponential phase to early exponential phase and late exponential phase to early exponential phase. &#x3a6; indicates significant values, p-value less than 0.05. * Indicates an absolute fold change greater than or equal to 1.5.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g007.tif"/>
</fig>
<p>Among the lipoproteins, AdcA and AdcAII were the prominent proteins with higher abundance, found in the late log phase in both the cytosolic fraction and extracellular fraction. A significant increase of ABC_SBP_8 was observed at the late exponential phase in the extracellular fraction, whereas other ABC-SBP (-SBP_1 and &#x2013;SBP_7) components remained unchanged throughout growth. Furthermore, MsmE, ArtP_1, RS04305, and AliB as subunit of the Ami oligopeptide ABC transporter showed higher abundance in the late log phase. AliA, another subunit of the Ami transporter system, did not exhibit significant changes in abundance during growth. Notably, MsrAB, as part of the detoxification system for oxidized proteins, was consistently detected in higher abundance across all growth conditions compared to the early exponential phase. Additionally, several other lipoproteins like LdcB or SdbB remained stable during growth (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<p>Significant differences in the abundance of sortase-anchored proteins compared to the early exponential phase were observed in the supernatant fraction. A notable increase in the abundance of EndoD, which contains an Ig-like domain, was found in the extracellular fraction. Additionally, increases were also observed for Eng, ZmpB, and PfbA. In contrast, the neuraminidase NanA level remained unchanged during growth, and similarly, SpnHL SpuA, StrH and PspC_2 did not exhibit alterations. A decreased abundance was detected for the adhesion PavB in the late exponential growth phase. Furthermore, decreases in NanA and StrH levels were observed in the cytoplasmic fraction during exponential growth phases (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<p>The non-classical surface proteins (NCSP) like enolase (Eno) and GAPDH (Gap) were found in abundance in both the cytosol and the supernatant (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). They were observed in the early exponential phase and significantly increased during the mid-exponential phase (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). Notably, PavA (pneumococcal adherence and virulence factor) lacking a secretion signal and domains for cell surface anchoring increased significantly during the late exponential phase in the supernatant fraction.</p>
<p>Proteases and peptidases are essential for multiple physiological processes in bacteria. Most of the proteases and peptidases discussed in this study (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>) maintains important cellular functions attributing to survival, adaptability and pathogenesis (<xref ref-type="bibr" rid="B60">Marquart, 2021</xref>). The typical Clp protease components (ClpP, ClpX, ClpC and ClpE) and the chaperone ClpL, were found in both fractions. The ClpP ratio decreased in the cytoplasmatic fraction during the late exponential phase compared to the early growth phase, however there is no significant change in either fraction during the exponential growth. Interestingly, out of the three extracellular serine proteases present in the colonizing strain, EF3030, the secreted serine proteases PrtA and HtrA were identified in both the fractions. No significant change of HtrA was observed during the exponential growth. In the cytosol, PrtA significantly reduced more than 1.5-fold during the late exponential phase, however it increased significantly in the supernatant during the exponential growth (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4A</bold>
</xref>). CbpG, the third serine protease was not detected under our experimental conditions. YdcP_2, a member of the U32 family peptidases, showed an increased abundance during growth in both fractions.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Heat maps illustrating a selection of proteases and peptidases with two or more peptides detected both in the cytosol and the supernatant of strain EF3030 by mass spectrometry analysis. The heat maps represent the signal log ratio values between mid-exponential phase to early exponential phase and late exponential phase to early exponential phase. &#x3a6; indicates significant values, p-value less than 0.05. * Indicates an absolute fold change greater than or equal to 1.5.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1606161-g008.tif"/>
</fig>
<p>Among the pneumococcal peptidases, PepX and PepO exhibited increased abundance during late exponential phase in the cytoplasmic fraction compared to the early exponential phase, whereas PepS and AlbF showed a decrease in abundance during growth. Most of these peptidases had a decreased abundance during exponential growth in the extracellular fraction. AlbF was an exception, with a small increase in abundance observed at the late exponential phase.</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Understanding the dynamics of protein production during pneumococcal growth, colonization, or invasive disease is essential for elucidating the molecular mechanisms underlying the pathophysiology of these pathobionts. This knowledge is important for identifying vaccine candidates and defining new targets for therapeutic interventions as well as developing sophisticated diagnostic tools. Our study employed an optimized minimal medium (CDM+) mimicking a nutrient-limited host compartment, such as the URT, to characterize the proteomic landscape of the colonizing serotype 19F strain EF3030.</p>
<p>To cultivate the pneumococcal strains under nasopharynx-mimicking conditions, a chemically defined medium (CDM) based on RPMI 1640 was initially formulated that included components such as bicarbonate, glutamine, glycine, choline chloride, and adenine-uracil (<xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>). The nasopharyngeal environment is characterized by low CO<sub>2</sub> levels; therefore, bicarbonate was added in the minimal medium CDM, which provides an alternative source of hydrogen carbonate (HCO<sub>3</sub>
<sup>&#x2212;</sup>). This was particularly relevant given the findings of Burghout and colleagues, which highlighted the importance of carbonic anhydrase (PCA) activity in pneumococcal adaptation to CO<sub>2</sub>-poor conditions (<xref ref-type="bibr" rid="B13">Burghout et&#xa0;al., 2013</xref>). Carbonic anhydrase facilitates the reversible conversion of CO<sub>2</sub> to bicarbonate, which is essential for fatty acid biosynthesis and polyglutamyl folate biosynthesis. No significant changes in carbonic anhydrase (MtcA1) levels were observed in our presented dataset, reinforcing the idea that it was not required due to the bicarbonate supplementation in the minimal medium. Additionally, several proteins from the <italic>fab</italic> gene cluster involved in fatty acid biosynthesis, such as FabD and FabG, showed significantly higher abundance in both the cytosolic fraction and the supernatant during the late exponential phase of our study. Furthermore, the increased presence of FabK and FabZ in the supernatant during the late logarithmic phase suggests that the bacteria are directly utilizing bicarbonate to support growth and fatty acid synthesis. Additionally, we included glutamine in CDM because <italic>S. pneumoniae</italic> is auxotrophic for glutamine (Gln) (<xref ref-type="bibr" rid="B36">H&#xe4;rtel et&#xa0;al., 2011</xref>). Glutamine, taken up by a glutamine ABC transporter system, is crucial for pneumococcal metabolism and serves as a precursor for amino acids and nucleotides. Deprivation of glutamine has been shown to impair bacterial growth and virulence (<xref ref-type="bibr" rid="B36">H&#xe4;rtel et&#xa0;al., 2011</xref>). Uracil, another component of CDM was included because it has been previously identified as a limiting factor for pneumococcal growth (<xref ref-type="bibr" rid="B16">Carvalho et&#xa0;al., 2013</xref>).</p>
<p>To further optimize the CDM medium and growth of streptococcal and pneumococcal strains, we developed CDM+ by supplementing CDM with iron, manganese, and methionine. <italic>S. pneumoniae</italic> has a relatively low iron requirement, as it lacks a respiratory chain and does not contain cytochromes (<xref ref-type="bibr" rid="B54">Lanie et&#xa0;al., 2007</xref>). Nevertheless, the bacterium still requires iron for enzymes that contain iron-sulfur (FeS) clusters, such as anaerobic ribonucleotide reductase (<xref ref-type="bibr" rid="B54">Lanie et&#xa0;al., 2007</xref>). Previous studies have shown that <italic>S. pneumoniae</italic> strain TIGR4 exhibits reduced growth under iron-depleted conditions, which can be restored with iron supplementation (<xref ref-type="bibr" rid="B31">Gupta et&#xa0;al., 2009</xref>). In low-iron environments, pneumococci form long chains, indicative of impaired cell separation. Furthermore, mutations in the genes encoding the ABC transporters responsible for iron acquisition (PiaABCD and PiuBCDA) attenuated the virulence of <italic>S. pneumoniae</italic> in a mouse infection model (<xref ref-type="bibr" rid="B11">Brown et&#xa0;al., 2001</xref>, <xref ref-type="bibr" rid="B12">2002</xref>).</p>
<p>Interestingly, in the present study, the strains, EF3030, TIGR4 and D39 exhibited clumping in CDM<bold>+</bold>, suggesting that the presence of iron may be a contributing factor. Previous studies also showed that elevated hemoglobin levels induce pneumococcal clustering and the secretion of factors that promote cell aggregation, suggesting adhesion and biofilm formation (<xref ref-type="bibr" rid="B31">Gupta et&#xa0;al., 2009</xref>).</p>
<p>Manganese was included in CDM+ as it is also an essential element in most organisms, serving as a cofactor for many enzymes involved in phosphorylation, hydrolysis, carbon metabolism, decarboxylation, and oxidative stress (<xref ref-type="bibr" rid="B22">Eijkelkamp et&#xa0;al., 2014</xref>). Pneumococcal proteins involved in manganese acquisition, such as MntE, NrdEF, SodD, PsaA, PsaR, and PhpP have a critical role in maintaining manganese homeostasis. When manganese levels are excessive, <italic>S. pneumoniae</italic> employs mechanism to cope with the situation by reducing Mn uptake via the PsaABC transporter system, increasing Mn efflux (MntE), and inhibiting the Fe transport system (<xref ref-type="bibr" rid="B61">Martin et&#xa0;al., 2017</xref>). Our proteome data identified MntE, PsaA, MntR and PhpP in both cytosol and the supernatant supporting the role of manganese in cellular processes during growth in CDM+.</p>
<p>Building on this optimized medium, we focused our analysis on the protein profiles of <italic>S. pneumoniae</italic> EF3030 across three distinct growth phases: early (OD<sub>600</sub> 0.4), mid (OD<sub>600</sub> 0.6), and late exponential phase (OD<sub>600</sub> 1.0). Protein abundance was systematically assessed in both the cytoplasmic and culture supernatant fractions, providing a comprehensive view of the dynamic changes in protein abundance as the bacteria transitioned through different stages of growth. In addition, we compared the overall changes in proteome profiles in pneumococcal strains D39V, TIGR4&#x394;<italic>cps</italic>, and EF3030 cultured in CDM+ to assess the applicability of our findings across different strains. D39V is a serotype 2 strain commonly used in virulence studies and experiments elucidating host-pathogen interaction. Similarly, TIGR4&#x394;<italic>cps</italic> (capsule mutant of serotype 4) is also known for its high virulence under <italic>in vivo</italic> conditions and used in particular to investigate the impact of virulence factors for pneumococcal pneumonia but also meningitis. Although all strains were cultivated in the CDM+ medium, however, it is important to mention, that medium batches, scientists as well as the analysis strategies of the proteome data slightly differed. Proteomic data of TIGR4&#x394;<italic>cps</italic> was obtained from an in-house pilot-study (unpublished data) and proteomic data of D39V was obtained from the PRIDE Project PXD061622. The general changes in the proteome profiles of later growth phases were compared to the early exponential growth phase. EF3030 and TIGR4&#x394;<italic>cps</italic> were compared at OD<sub>600</sub> 1.0 to OD<sub>600</sub> 0.4 and the strain D39V was compared at OD<sub>600</sub> 1.5 to OD<sub>600</sub> 0.5. We used a GSEA analysis of the known regulons in <italic>S. pneumoniae</italic> as shown in the cluster plot in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>. We observed mainly changes in protein abundances of the regulons associated with metabolism in all three strains such as the sugar metabolism regulons CcpA and MalR which (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S6</bold>
</xref>) were higher in abundance during early stages of growth. We observe a much lower abundance of CcpA in EF3030 compared to the invasive strains during the late exponential phase. The invasive strains, but with more pronounced results especially the strain D39V, showed a general decrease of protein abundance of the CodY and FabT regulon compared to EF3030. This indicates metabolic differences between invasive and non-invasive strains. However, there seem to be also differences in the regulons of TIGR4 and D39V, which have already been identified earlier, when analyzing the arginine deiminase system and its regulation in TIGR4 and D39 (<xref ref-type="bibr" rid="B79">Schulz et&#xa0;al., 2014</xref>). In addition, D39V showed a decrease of competence-related proteins (ComX1, ComE regulon) in the later growth phase. This is consistent with competence development during the initial exponential growth phase (<xref ref-type="bibr" rid="B99">Zhang et&#xa0;al., 2023</xref>). Furthermore, the three strains showed differences between the accumulation of zinc scavenging systems during the later growth phase compared to the early growth phase. The major regulators were compared between these strains to have an insight regarding strain specific differences. Further an extended comparative analysis of the non-invasive and invasive strains would be valuable as a proteogenomic study on pangenome level.</p>
<p>From the EF3030 proteome data, notably, surface-associated and secreted proteins, which are crucial for pathogen-host interactions, exhibited significant variations in abundance depending on the growth phase. These proteins, including choline-binding proteins (CBPs), sortase-anchored proteins, and lipoproteins, are directly involved in bacterial adhesion, invasion, or immune evasion mechanisms and contribute to pneumococcal fitness. As such, they represent promising candidates for the development of vaccines and therapeutic strategies (<xref ref-type="bibr" rid="B64">Morsczeck et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B77">Rigden et&#xa0;al., 2003</xref>).</p>
<p>We identified over 1344 proteins that are common to both the supernatant and cellular fraction, suggesting a high rate of pneumococcal lysis in the medium already at the early stage of growth. This could be attributed to CbpD, a murein hydrolase, which showed a remarkable 54-fold increase in abundance in the extracellular fraction during the late exponential phase. However, even at lower levels early on, it may still trigger lysis in a subset of cells, potentially initiating a cascade effect. CbpD causes lysis on its own and promotes an activation on LytA and LytC (<xref ref-type="bibr" rid="B47">Kausmally et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B23">Eldholm et&#xa0;al., 2009</xref>). The abundance of LytA increased in both the cytosol and the supernatant during exponential growth, although this increase was not statistically significant. In contrast, LytC was not detectable in our experimental conditions. We hypothesize that CbpD lyses non-competent sister cells, a process that is referred to as allolysis (<xref ref-type="bibr" rid="B30">Guiral et&#xa0;al., 2005</xref>), and the LytA from these cells promotes in-trans lysis of competent pneumococcal cells.</p>
<p>As <italic>S. pneumoniae</italic> colonizes the nasopharynx, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) production is thought to play a role in inhibiting competing microbes. SpxB, a pyruvate oxidase and the key enzyme for H<sub>2</sub>O<sub>2</sub> production, was detected in higher abundance in the supernatant during the mid-exponential phase (OD<sub>600</sub> 0.6) and reduced during the later growth phase. The early expression of pyruvate oxidase during bacterial growth has also been reported in other studies (<xref ref-type="bibr" rid="B73">Pericone et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B55">Lee et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B5">B&#xe4;ttig and M&#xfc;hlemann, 2008</xref>) coinciding with the time when pneumococci reach competence (<xref ref-type="bibr" rid="B5">B&#xe4;ttig and M&#xfc;hlemann, 2008</xref>). Previous studies have demonstrated that the deletion of <italic>spxB</italic> abolishes spontaneous transformation, reduces the expression of early competence gene <italic>comC</italic>, and diminishes competence-associated DNA release (<xref ref-type="bibr" rid="B5">B&#xe4;ttig and M&#xfc;hlemann, 2008</xref>). However, the role of SpxB products, H<sub>2</sub>O<sub>2</sub>, in these processes remains unclear. Interestingly, we failed to detect ComC, while we observed a higher abundance of ComB, a protein required for transformation, in the supernatant during the late exponential phases compared to the early exponential phase. Additionally, the late competence-associated proteins ComGA, which are essential for DNA uptake (<xref ref-type="bibr" rid="B4">Balaban et&#xa0;al., 2014</xref>), were found in significantly higher abundance both in the supernatant and cytosol, with a nearly 5-fold increase in the supernatant during the late exponential phase compared to both early and mid-exponential phase. Moreover, ComEA, a major component of&#xa0;DNA uptake apparatus for transformation was exclusively found in the supernatant, also increased in abundance during the late exponential phase. A study by Liu and colleagues have demonstrated that the receptor ComEA plays a significant role in the uptake of dsDNA during bacterial transformation, whereas HtrA, a serine protease, specifically degrades ComEA and ComEC to terminate the process (<xref ref-type="bibr" rid="B58">Liu et&#xa0;al., 2019</xref>). Other proteins involved in processing internalized single-stranded DNA (ssDNA), such as Dpr, DprA, and SsbB, were also found in higher abundance, although not always statistically significant, in both the cytosol and supernatant during the late exponential phase. <italic>S. pneumoniae</italic> cultivated in the minimal medium retains the ability to take up foreign DNA during the later stages of growth (<xref ref-type="bibr" rid="B18">Claverys et&#xa0;al., 2006</xref>). Altogether, these findings provide insights into the timing and regulation of competence and lysis in <italic>S. pneumoniae</italic>, highlighting the dynamic interplay between protein expression, autolysis, and DNA uptake during bacterial growth and colonization. In addition, this demonstrates that the medium allows competence development in <italic>S. pneumoniae</italic> EF3030 during the exponential growth phase.</p>
<p>In our proteomic analysis of <italic>S. pneumoniae</italic> EF3030, we observed a significant increase in pneumolysin abundance (p-value &lt; 0.05) from the early (OD<sub>600</sub> 0.4) to the late exponential phase (OD<sub>600</sub> 1.0) in the cytosolic fraction. However, this increase was not significant in the supernatant. In addition to pneumolysin, we identified several immunogenic proteins including PspC, PcpA, PrtA, PcsB, PhtD, PsaA, AliB, PavB, SatA, PnrA, PpmA, PspA, AmiA, LytN, and EF3030_RS10100 in both the cytosol and supernatant during the exponential growth phase. Serological profiling of pneumococcal proteins (<xref ref-type="bibr" rid="B37">He et&#xa0;al., 2024</xref>) and other studies have revealed that these proteins exhibit the highest IgG levels and are considered as vaccine candidates (<xref ref-type="bibr" rid="B83">Sempere et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B48">Khan and Pichichero, 2012</xref>; <xref ref-type="bibr" rid="B90">Tai, 2006</xref>). This suggests that the secretion of these proteins is a common phenomenon in <italic>S. pneumoniae</italic> during the exponential growth phase. Notably, both HtrA and PrtA, two serine proteases in <italic>S. pneumoniae</italic>, were detected in our dataset. While pneumococci typically harbor up to four secreted serine proteases (HtrA, PrtA, CbpG, and SFP) depending on the strain (<xref ref-type="bibr" rid="B2">Ali et&#xa0;al., 2021a</xref>), EF3030 lacks SFP. We did not detect CbpG in our experiments including tryptic peptides with up to two cleavages, however, we found both HtrA and PrtA in the early exponential phase (OD<sub>600</sub> 0.4). There was no significant fold change of HtrA during growth but PrtA showed a significant increase in the supernatant during exponential growth, further highlighting the dynamic protein secretion during this phase. The cultivation of EF3030 in the minimal medium also revealed a higher abundance of several zinc-acquisition proteins, including the AdcA and AdcAII transporters, the repressor AdcR, and the pneumococcal histidine triad (Pht) proteins. The Pht proteins, in particular, are known virulence factors in <italic>S. pneumoniae</italic>, with promising potential in preclinical vaccine trials aimed at preventing pneumococcal colonization and disease (<xref ref-type="bibr" rid="B1">Adamou et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B29">Godfroid et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B20">Deno&#xeb;l et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B82">Seiberling et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B75">Plumptre et&#xa0;al., 2013</xref>). Studies have shown that the genes encoding for AdcAII and PhtD are part of an operon regulated by the repressor AdcR. PhtD serves as an extracellular Zn<sup>2+</sup> scavenger, acting as a metallophore for zinc acquisition and potentially transferring captured Zn<sup>2+</sup> to the AdcAII transporter or forming a complex with AdcAII, linking zinc sensing to virulence (<xref ref-type="bibr" rid="B59">Loisel et&#xa0;al., 2011</xref>). In the presence of zinc, AdcR directly represses the <italic>adcRCBA</italic> genes and <italic>adcII, phtA, phtB, phtD</italic>, and <italic>phtE</italic> (<xref ref-type="bibr" rid="B84">Shafeeq et&#xa0;al., 2011</xref>).</p>
<p>Studies have shown that a lack of zinc (Zn) increases the risk of severe invasive pneumococcal infections and mortality. Research by (<xref ref-type="bibr" rid="B86">Strand et&#xa0;al., 2001</xref>) provides direct evidence that individuals with Zn deficiency experience more severe pneumococcal infections. Furthermore, a study by (<xref ref-type="bibr" rid="B87">Strand et&#xa0;al., 2003</xref>) reported that Zn deficiency not only worsens the infection but also weakens the body&#x2019;s ability to produce specific antibodies against PspA. This leads to higher bacterial colonization in mucosal tissues, increasing the likelihood of invasive disease and death. On the other hand, research by (<xref ref-type="bibr" rid="B9">Bhandari et&#xa0;al., 2002</xref>) demonstrated that providing zinc supplements to children in developing countries significantly lowers the occurrence of pneumonia.</p>
<p>Given that our experiments were conducted under zinc-limiting conditions, the significant increase in Zn<sup>2+</sup> transporters and Pht proteins is consistent with the bacterium&#x2019;s need to scavenge zinc from its environment. This aligns with previous studies showing that Zn depletion weakens host immunity and increases pneumococcal colonization and virulence, further emphasizing the role of Zn in controlling pneumococcal infections. These findings suggest that supplementing the culture medium with zinc could reduce or eliminate the high abundance of these proteins, highlighting the adaptive mechanisms <italic>S. pneumoniae</italic> employs to thrive in zinc-limited conditions during infection.</p>
<p>Finally, a comprehensive understanding of the proteome profile during <italic>S. pneumoniae</italic> growth provides valuable insights into the molecular mechanisms underlying its colonization and pathogenicity. This knowledge can be leveraged to identify potential vaccine targets by highlighting key proteins involved in host interaction, immune evasion, and virulence. Additionally, it could aid in the development of strategies to block critical resistance factors, such as antibiotic efflux pumps, or surface adhesins, thereby enhancing therapeutic options. Ultimately, these findings contribute to a more detailed understanding of pneumococcal biology, which is essential for designing more effective treatments and preventive measures against this pathogen.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>This study provides a detailed proteomic profile of <italic>S. pneumoniae</italic> EF3030, revealing growth-dependent changes in both the cellular and extracellular proteomes. The identified proteins, particularly those involved in transport, regulation, metabolism, and virulence, offer valuable insights into the bacterial adaptation to varying growth conditions and the potential targets for therapeutic interventions. The characterization of these proteomic shifts significantly advances our understanding of pneumococcal physiology and its response to host environments.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the PRIDE repository, accession number PXD062379&#x201d; (<uri xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD062379">https://www.ebi.ac.uk/pride/archive/projects/PXD062379</uri>).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>SD: Writing &#x2013; original draft, Formal analysis, Visualization, Methodology, Data curation, Investigation. LB: Formal analysis, Writing &#x2013; review &amp; editing, Software, Visualization, Validation. GB:&#xa0;Writing &#x2013; review &amp; editing, Supervision, Formal analysis. MGS: Writing &#x2013; review &amp; editing, Software, Formal analysis, Validation. RS: Investigation, Writing &#x2013; review &amp; editing, Methodology, Resources, Visualization. LS: Software, Data curation, Investigation, Writing &#x2013; review &amp; editing, Validation, Formal analysis. UV: Supervision, Validation, Funding acquisition, Writing &#x2013; review &amp; editing, Resources, Project administration. SH: Funding acquisition, Formal analysis, Resources, Project administration, Supervision, Conceptualization, Validation, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This project is funded by the Grants from the Deutsche Forschungsgemeinschaft, DFG-GRK 2719/1 (to SH and UV).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We like to thank Katrin Schoknecht (University Medicine Greifswald), Birgit Rietow (University of Greifswald) and Stefan Bock (University of Greifswald) for technical assistance, Vera Fuentes Moreno and Luca Cagnini for supporting experimental work, Prof. Dr. Anders Hakansson, Lund University, Sweden for kindly providing the 19F, EF3030 strain. The data illustrations were created with GraphPad Prism, version 8.4.3 (686), Microsoft Excel and R version 4.4.1. The language was improved using OpenAI, ChatGPT.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that Generative AI was used in the creation of this manuscript. The language was improved using OpenAI, ChatGPT.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1606161/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1606161/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Table2.xlsx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table3.xlsx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table4.xlsx" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamou</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Heinrichs</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Erwin</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Gayle</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dormitzer</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis</article-title>. <source>Infection Immun.</source> <volume>69</volume>, <fpage>949</fpage>&#x2013;<lpage>958</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.69.2.949-958.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11159990</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname> <given-names>M. Q.</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Burchhardt</surname> <given-names>G.</given-names>
</name>
<name>
<surname>W&#xfc;st</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Henck</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bolsmann</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Extracellular pneumococcal serine proteases affect nasopharyngeal colonization</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>10</volume>, <elocation-id>613467</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.613467</pub-id>, PMID: <pub-id pub-id-type="pmid">33659218</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname> <given-names>M. Q.</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Schulig</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Burchhardt</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>b). <article-title>Pneumococcal extracellular serine proteases: molecular analysis and impact on colonization and disease</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>11</volume>, <elocation-id>763152</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.763152</pub-id>, PMID: <pub-id pub-id-type="pmid">34790590</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balaban</surname> <given-names>M.</given-names>
</name>
<name>
<surname>B&#xe4;ttig</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Muschiol</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tirier</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Wartha</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Normark</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Secretion of a pneumococcal type II secretion system pilus correlates with DNA uptake during transformation</article-title>. <source>Proc. Natl. Acad. Sci. United States America</source> <volume>111</volume>, <fpage>E758</fpage>&#x2013;<lpage>E765</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1313860111</pub-id>, PMID: <pub-id pub-id-type="pmid">24550320</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xe4;ttig</surname> <given-names>P.</given-names>
</name>
<name>
<surname>M&#xfc;hlemann</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Influence of the spxB gene on competence in Streptococcus pneumoniae</article-title>. <source>J. bacteriology</source> <volume>190</volume>, <fpage>1184</fpage>&#x2013;<lpage>1189</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.01517-07</pub-id>, PMID: <pub-id pub-id-type="pmid">18065543</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmann</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Versatility of pneumococcal surface proteins</article-title>. <source>Microbiol. (Reading England)</source> <volume>152</volume>, <fpage>295</fpage>&#x2013;<lpage>303</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.28610-0</pub-id>, PMID: <pub-id pub-id-type="pmid">16436417</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmann</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Fibrinolysis and host response in bacterial infections</article-title>. <source>Thromb. Haemostasis</source> <volume>98</volume>, <fpage>512</fpage>&#x2013;<lpage>520</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1160/TH07-02-0117</pub-id>, PMID: <pub-id pub-id-type="pmid">17849039</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bersch</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Bougault</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Roux</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Favier</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vernet</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Durmort</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>New insights into histidine triad proteins: solution structure of a Streptococcus pneumoniae PhtD domain and zinc transfer to AdcAII</article-title>. <source>PloS One</source>  <volume>8</volume> (<issue>11</issue>), <elocation-id>e81168</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0081168</pub-id>, PMID: <pub-id pub-id-type="pmid">24312273</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhandari</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bahl</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Taneja</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Strand</surname> <given-names>T.</given-names>
</name>
<name>
<surname>M&#xf8;lbak</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Johan Ulvik</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children</article-title>. <source>Pediatrics</source> <volume>109</volume> (<issue>6</issue>), pp.<fpage>e86</fpage>-<lpage>e86</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.324.7350.1358</pub-id>, PMID: <pub-id pub-id-type="pmid">12042580</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogaert</surname> <given-names>D.</given-names>
</name>
<name>
<surname>de Groot</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hermans</surname> <given-names>P. W. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Streptococcus pneumoniae colonisation: the key to pneumococcal disease</article-title>. <source>Lancet Infect. Dis.</source> <volume>4</volume>, <fpage>144</fpage>&#x2013;<lpage>154</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1473-3099(04)00938-7</pub-id>, PMID: <pub-id pub-id-type="pmid">14998500</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Gilliland</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Holden</surname> <given-names>D. W.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence</article-title>. <source>Mol. Microbiol.</source> <volume>40</volume>, <fpage>572</fpage>&#x2013;<lpage>585</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02414.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11359564</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Gilliland</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Ruiz-Albert</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Holden</surname> <given-names>D. W.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter</article-title>. <source>Infection Immun.</source> <volume>70</volume>, <fpage>4389</fpage>&#x2013;<lpage>4398</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.70.8.4389-4398.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12117949</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burghout</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zomer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>van der Gaast-de Jongh</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Janssen-Megens</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Fran&#xe7;oijs</surname> <given-names>K.-J.</given-names>
</name>
<name>
<surname>Stunnenberg</surname> <given-names>H. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Streptococcus pneumoniae folate biosynthesis responds to environmental CO2 levels</article-title>. <source>J. bacteriology</source> <volume>195</volume>, <fpage>1573</fpage>&#x2013;<lpage>1582</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.01942-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23354753</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartwright</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management</article-title>. <source>Eur. J. Pediatr.</source> <volume>161</volume>, <fpage>188</fpage>&#x2013;<lpage>195</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00431-001-0907-3</pub-id>, PMID: <pub-id pub-id-type="pmid">12014384</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Kloosterman</surname> <given-names>T. G.</given-names>
</name>
<name>
<surname>Kuipers</surname> <given-names>O. P.</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>A. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>CcpA ensures optimal metabolic fitness of Streptococcus pneumoniae</article-title>. <source>PloS One</source> <volume>6</volume>, <elocation-id>e26707</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0026707</pub-id>, PMID: <pub-id pub-id-type="pmid">22039538</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Kuipers</surname> <given-names>O. P.</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>A. R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Environmental and nutritional factors that affect growth and metabolism of the pneumococcal serotype 2 strain D39 and its nonencapsulated derivative strain R6</article-title>. <source>PloS One</source> <volume>8</volume>, <elocation-id>e58492</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0058492</pub-id>, PMID: <pub-id pub-id-type="pmid">23505518</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Marks</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Pettigrew</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Hakansson</surname> <given-names>A. P.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>4</volume>, <fpage>194</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2014.00194</pub-id>, PMID: <pub-id pub-id-type="pmid">25629011</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claverys</surname> <given-names>J.-P.</given-names>
</name>
<name>
<surname>Prudhomme</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Induction of competence regulons as a general response to stress in gram-positive bacteria</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>60</volume>, <fpage>451</fpage>&#x2013;<lpage>475</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.micro.60.080805.142139</pub-id>, PMID: <pub-id pub-id-type="pmid">16771651</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hakansson</surname> <given-names>A. P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Measuring niche-associated metabolic activity in planktonic and biofilm bacteria</article-title>. <source>Methods and Protocols</source> (pp. <fpage>3</fpage>-<lpage>32</lpage>). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer US</publisher-name>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-0716-3243-7_1</pub-id>, PMID: <pub-id pub-id-type="pmid">37258957</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deno&#xeb;l</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Philipp</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Doyle</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Carletti</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Poolman</surname> <given-names>J. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A proteinbased pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae</article-title>. <source>Vaccine</source> <volume>29</volume>, <fpage>5495</fpage>&#x2013;<lpage>5501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.05.051</pub-id>, PMID: <pub-id pub-id-type="pmid">21624422</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deutsch</surname> <given-names>E. W.</given-names>
</name>
<name>
<surname>Bandeira</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Perez-Riverol</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Carver</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Mendoza</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>The ProteomeXchange consortium at 10 years: 2023 update</article-title>. <source>Nucleic Acids Res.</source> <volume>51</volume>, <fpage>D1539</fpage>&#x2013;<lpage>D1548</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkac1040</pub-id>, PMID: <pub-id pub-id-type="pmid">36370099</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eijkelkamp</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Morey</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Ween</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Ong</surname> <given-names>C. Y.</given-names>
</name>
<name>
<surname>McEwan</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Paton</surname> <given-names>J. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Extracellular zinc competitively inhibits manganese uptake and compromises oxidative stress management in Streptococcus pneumoniae</article-title>. <source>PloS One</source> <volume>9</volume>, <elocation-id>e89427</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0089427</pub-id>, PMID: <pub-id pub-id-type="pmid">24558498</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eldholm</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Johnsborg</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Haugen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ohnstad</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>H&#xe5;varstein</surname> <given-names>L. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD, LytA and LytC</article-title>. <source>Microbiol. (Reading England)</source> <volume>155</volume>, <fpage>2223</fpage>&#x2013;<lpage>2234</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.026328-0</pub-id>, PMID: <pub-id pub-id-type="pmid">19389766</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elm</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Rohde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Vaerman</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Chhatwal</surname> <given-names>G. S.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Characterization of the interaction of the pneumococcal surface protein SpsA with the human polymeric immunoglobulin receptor (hpIgR)</article-title>. <source>Indian Journal of Medical Research</source>, <volume>119</volume>, pp.<fpage>61</fpage>-<lpage>65</lpage>., PMID: <pub-id pub-id-type="pmid">15232164</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatykhova</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Fritsch</surname> <given-names>V. N.</given-names>
</name>
<name>
<surname>Siebert</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Methling</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lalk</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Busche</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus</article-title>. <source>Eur. Respir. J.</source> <volume>64</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/13993003.01983-2023</pub-id>, PMID: <pub-id pub-id-type="pmid">39231629</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frankel</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Hendrickx</surname> <given-names>A. P. A.</given-names>
</name>
<name>
<surname>Missiakas</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Schneewind</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>LytN, a murein hydrolase in the cross-wall compartment of Staphylococcus aureus, is involved in proper bacterial growth and envelope assembly</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>32593</fpage>&#x2013;<lpage>32605</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.258863</pub-id>, PMID: <pub-id pub-id-type="pmid">21784864</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritsch</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Handtke</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Ozhiganova</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jahn</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Pneumococcal neuraminidases increase platelet killing by pneumolysin</article-title>. <source>Thromb. haemostasis</source> <volume>125</volume>, <fpage>243</fpage>&#x2013;<lpage>254</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/a-2369-8680</pub-id>, PMID: <pub-id pub-id-type="pmid">39029905</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilley</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Orihuela</surname> <given-names>C. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>4</volume>, <elocation-id>163</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2014.00163</pub-id>, PMID: <pub-id pub-id-type="pmid">25414838</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godfroid</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Hermand</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Verlant</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Deno&#xeb;l</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Poolman</surname> <given-names>J. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens</article-title>. <source>Infection Immun.</source> <volume>79</volume>, <fpage>238</fpage>&#x2013;<lpage>245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00378-10</pub-id>, PMID: <pub-id pub-id-type="pmid">20956575</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guiral</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Claverys</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>102</volume> (<issue>24</issue>), p.<fpage>68</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0500879102</pub-id>, PMID: <pub-id pub-id-type="pmid">15928084</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Swiatlo</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Differential gene expression in Streptococcus pneumoniae in response to various iron sources</article-title>. <source>Microbial pathogenesis</source> <volume>47</volume>, <fpage>101</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2009.05.003</pub-id>, PMID: <pub-id pub-id-type="pmid">19464356</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haft</surname> <given-names>D. H.</given-names>
</name>
<name>
<surname>Selengut</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Richter</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Harkins</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Basu</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Beck</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>TIGRFAMs and genome properties in 2013</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>D387</fpage>&#x2013;<lpage>D395</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gks1234</pub-id>, PMID: <pub-id pub-id-type="pmid">23197656</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall-Stoodley</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Costerton</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Stoodley</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Bacterial biofilms: from the natural environment to infectious diseases</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>2</volume>, <fpage>95</fpage>&#x2013;<lpage>108</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro821</pub-id>, PMID: <pub-id pub-id-type="pmid">15040259</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Adherence molecules of pathogenic pneumococci</article-title>. <source>Curr.&#xa0;Opin. Microbiol.</source> <volume>9</volume>, <fpage>12</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mib.2005.11.001</pub-id>, PMID: <pub-id pub-id-type="pmid">16338163</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;rtel</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Eylert</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Petruschka</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gierok</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Grubm&#xfc;ller</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Characterization of central carbon metabolism of Streptococcus pneumoniae by isotopologue profiling</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>4260</fpage>&#x2013;<lpage>4274</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.304311</pub-id>, PMID: <pub-id pub-id-type="pmid">22167202</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;rtel</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Koedel</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Rohde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Petruschka</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Impact of glutamine transporters on pneumococcal fitness under infection-related conditions</article-title>. <source>Infection Immun.</source> <volume>79</volume>, <fpage>44</fpage>&#x2013;<lpage>58</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00855-10</pub-id>, PMID: <pub-id pub-id-type="pmid">21078855</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>S. W. J.</given-names>
</name>
<name>
<surname>Vo&#xdf;</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Nicolaie</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Brummelman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>van de Garde</surname> <given-names>M. D. B.</given-names>
</name>
<name>
<surname>Bijvank</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance, and waning of antibodies throughout life</article-title>. <source>J. Infect. Dis.</source> <volume>230</volume>, <fpage>e1299</fpage>&#x2013;<lpage>e1310</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiae216</pub-id>, PMID: <pub-id pub-id-type="pmid">38679601</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendriksen</surname> <given-names>W. T.</given-names>
</name>
<name>
<surname>Bootsma</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Estev&#xe3;o</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hoogenboezem</surname> <given-names>T.</given-names>
</name>
<name>
<surname>de Jong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>de Groot</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization</article-title>. <source>J. bacteriology</source> <volume>190</volume>, <fpage>590</fpage>&#x2013;<lpage>601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00917-07</pub-id>, PMID: <pub-id pub-id-type="pmid">18024519</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Im</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kruckow</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>D'Mello</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ganaie</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Luck</surname> <given-names>J. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Anatomical Site-Specific Carbohydrate Availability Impacts Streptococcus pneumoniae Virulence and Fitness during Colonization and Disease</article-title>. <source>Infection Immun.</source> <volume>90</volume>, <elocation-id>e0045121</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00451-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34748366</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Baliga</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Camilli</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae</article-title>. <source>J. bacteriology</source> <volume>187</volume>, <fpage>8340</fpage>&#x2013;<lpage>8349</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.187.24.8340-8349.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">16321938</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacoby</surname> <given-names>W. G.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Loess: a nonparametric, graphical tool for depicting relationships between variables</article-title>. <source>Electoral studies</source>, <volume>19</volume> (<issue>4</issue>), pp. <fpage>577</fpage>-<lpage>613</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0261-3794(99)00028-1</pub-id>
</citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensch</surname> <given-names>I.</given-names>
</name>
<name>
<surname>G&#xe1;mez</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Rothe</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fulde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Somplatzki</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections</article-title>. <source>Mol. Microbiol.</source> <volume>77</volume>, <fpage>22</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07189.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20444103</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Bootsma</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Aldridge</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Manuse</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gisch</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Schwudke</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Co-inactivation of GlnR and CodY regulators impacts pneumococcal cell wall physiology</article-title>. <source>PloS One</source> <volume>10</volume>, <elocation-id>e0123702</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0123702</pub-id>, PMID: <pub-id pub-id-type="pmid">25901369</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Junges</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Maienschein-Cline</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Petersen</surname> <given-names>F. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Complete genome sequence of streptococcus pneumoniae serotype 19F strain EF3030</article-title>. <source>Microbiol. resource announcements</source> <volume>8</volume> (<issue>19</issue>), pp.<fpage>10</fpage>-<lpage>1128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MRA.00198-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31072896</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kallio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sepponen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hermand</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Deno&#xeb;l</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Godfroid</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Melin</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells</article-title>. <source>Infection Immun.</source> <volume>82</volume>, <fpage>1683</fpage>&#x2013;<lpage>1691</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00699-13</pub-id>, PMID: <pub-id pub-id-type="pmid">24491577</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanwal</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jensch</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Palm</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Br&#xf6;nstrup</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rohde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Mapping the recognition domains of pneumococcal fibronectin-binding proteins PavA and PavB demonstrates a common pattern of molecular interactions with fibronectin type III repeats</article-title>. <source>Mol. Microbiol.</source> <volume>105</volume>, <fpage>839</fpage>&#x2013;<lpage>859</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.2017.105.issue-6</pub-id>, PMID: <pub-id pub-id-type="pmid">28657670</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kausmally</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Johnsborg</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Lunde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Knutsen</surname> <given-names>E.</given-names>
</name>
<name>
<surname>H&#xe5;varstein</surname> <given-names>L. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Cholinebinding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis</article-title>. <source>J. bacteriology</source> <volume>187</volume>, <fpage>4338</fpage>&#x2013;<lpage>4345</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.187.13.4338-4345.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15968042</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Pichichero</surname> <given-names>M. E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans</article-title>. <source>Vaccine</source> <volume>30</volume>, <fpage>2900</fpage>&#x2013;<lpage>2907</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.02.023</pub-id>, PMID: <pub-id pub-id-type="pmid">22349524</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname> <given-names>S. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Pneumococcal modification of host sugars: a major contributor to colonization of the human airway</article-title>. <source>Mol. Oral. Microbiol.</source> <volume>25</volume>, <fpage>15</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.2041-1014.2009.00564.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20331791</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohler</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vo&#xdf;</surname> <given-names>F.</given-names>
</name>
<name>
<surname>G&#xf3;mez Mejia</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion</article-title>. <source>FEBS Lett.</source> <volume>590</volume>, <fpage>3820</fpage>&#x2013;<lpage>3839</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/feb2.2016.590.issue-21</pub-id>, PMID: <pub-id pub-id-type="pmid">27508940</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korotkevich</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Sukhov</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Budin</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Shpak</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Artyomov</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Sergushichev</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Fast gene set enrichment analysis</article-title>. <source>biorxiv</source>, p.<fpage>060012</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/060012</pub-id>
</citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krismer</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Liebeke</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Janek</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Nega</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rautenberg</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hornig</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose</article-title>. <source>PloS Pathog.</source> <volume>10</volume>, <elocation-id>e1003862</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003862</pub-id>, PMID: <pub-id pub-id-type="pmid">24453967</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Tata</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Briles</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Orihuela</surname> <given-names>C. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A jack of all trades: the&#xa0;role of pneumococcal surface protein A in the pathogenesis of streptococcus pneumoniae</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>12</volume>, <elocation-id>826264</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.826264</pub-id>, PMID: <pub-id pub-id-type="pmid">35186799</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanie</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>W.-L.</given-names>
</name>
<name>
<surname>Kazmierczak</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Andrzejewski</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Davidsen</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Wayne</surname> <given-names>K. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6</article-title>. <source>J. bacteriology</source> <volume>189</volume>, <fpage>38</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.01148-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17041037</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>K.-J.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>S.-M.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>M.-R.</given-names>
</name>
<name>
<surname>Yeon</surname> <given-names>S.-M.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y.-H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K.-S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Proteomic analysis of growth phase-dependent proteins of Streptococcus pneumoniae</article-title>. <source>Proteomics</source> <volume>6</volume>, <fpage>1274</fpage>&#x2013;<lpage>1282</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pmic.200500415</pub-id>, PMID: <pub-id pub-id-type="pmid">16429463</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gierok</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Methling</surname> <given-names>K.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Mejia</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lalk</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Metabolic inventory of Streptococcus pneumoniae growing in a chemical defined environment</article-title>. <source>Int. J. Med. Microbiol. IJMM</source> <volume>308</volume>, <fpage>705</fpage>&#x2013;<lpage>712</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijmm.2018.01.001</pub-id>, PMID: <pub-id pub-id-type="pmid">29398251</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.-W.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Veening</surname> <given-names>J.-W.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.-R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Transcriptional repressor PtvR regulates phenotypic tolerance to vancomycin in streptococcus pneumoniae</article-title>. <source>J. bacteriology</source> <volume>199</volume> (<issue>14</issue>), pp.<fpage>10</fpage>-<lpage>1128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00054-17</pub-id>, PMID: <pub-id pub-id-type="pmid">28484041</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>HtrA-mediated selective degradation of DNA uptake apparatus accelerates termination of pneumococcal transformation</article-title>. <source>Mol. Microbiol.</source> <volume>112</volume>, <fpage>1308</fpage>&#x2013;<lpage>1325</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.v112.4</pub-id>, PMID: <pub-id pub-id-type="pmid">31396996</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loisel</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Chimalapati</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bougault</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Imberty</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gallet</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Di Guilmi</surname> <given-names>A. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Biochemical characterization of the histidine triad protein PhtD as a cell surface zinc-binding protein of pneumococcus</article-title>. <source>Biochemistry</source> <volume>50</volume>, <fpage>3551</fpage>&#x2013;<lpage>3558</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi200012f</pub-id>, PMID: <pub-id pub-id-type="pmid">21425866</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marquart</surname> <given-names>M. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases</article-title>. <source>Virulence</source> <volume>12</volume>, <fpage>766</fpage>&#x2013;<lpage>787</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2021.1889812</pub-id>, PMID: <pub-id pub-id-type="pmid">33660565</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Lisher</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Winkler</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Giedroc</surname> <given-names>D. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Perturbation of manganese metabolism disrupts cell division in Streptococcus pneumoniae</article-title>. <source>Mol. Microbiol.</source> <volume>104</volume>, <fpage>334</fpage>&#x2013;<lpage>348</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.2017.104.issue-2</pub-id>, PMID: <pub-id pub-id-type="pmid">28127804</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Steil</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Salazar</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Hentschker</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Surmann</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>SpectroPipeR-a streamlining post Spectronaut&#xae; DIA-MS data analysis R package</article-title>. <source>Bioinf. (Oxford England)</source> <volume>41</volume> (<issue>3</issue>), <elocation-id>btaf086</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btaf086</pub-id>, PMID: <pub-id pub-id-type="pmid">39985446</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Winther</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Teufel</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Predicting the subcellular location of prokaryotic proteins with DeepLocPro</article-title>. <source>Bioinformatics</source>, <volume>40</volume> (<issue>12</issue>), p.<fpage>btae677</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2024.01.04.574157</pub-id>, PMID: <pub-id pub-id-type="pmid">39540738</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morsczeck</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Prokhorova</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sigh</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pfeiffer</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bille-Nielsen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Petersen</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Streptococcus pneumoniae: proteomics of surface proteins for vaccine development</article-title>. <source>Clin. Microbiol. infection</source> <volume>14</volume>, <fpage>74</fpage>&#x2013;<lpage>81</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01878.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18034862</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narciso</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Dookie</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Nannapaneni</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Normark</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Henriques-Normark</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Streptococcus pneumoniae epidemiology, pathogenesis and control</article-title>. <source>Nat. Rev. Microbiol</source>. <volume>23</volume> (<issue>4</issue>), pp.<fpage>256</fpage>-<lpage>271</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-024-01116-z</pub-id>, PMID: <pub-id pub-id-type="pmid">39506137</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Roche</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Gould</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Chim</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ratner</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance</article-title>. <source>Infection Immun.</source> <volume>75</volume>, <fpage>83</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01475-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17088346</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novichkov</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Kazakov</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Ravcheev</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Leyn</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Kovaleva</surname> <given-names>G. Y.</given-names>
</name>
<name>
<surname>Sutormin</surname> <given-names>R. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>A resource for genome-scale exploration of transcriptional regulation in bacteria</article-title>. <source>BMC genomics</source>, <volume>14</volume>, pp.<fpage>1</fpage>-<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2164-14-745</pub-id>, PMID: <pub-id pub-id-type="pmid">24175918</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ong</surname> <given-names>C. Y.</given-names>
</name>
<name>
<surname>Potter</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Trappetti</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Jennings</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Paton</surname> <given-names>J. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Interplay between manganese and iron in pneumococcal pathogenesis: role of the orphan response regulator RitR</article-title>. <source>Infection Immun.</source> <volume>81</volume>, <fpage>421</fpage>&#x2013;<lpage>429</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00805-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23184523</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulikat</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Schwudke</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vo&#xdf;</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response</article-title>. <source>Front. Immunol.</source> <volume>15</volume>, <elocation-id>1392316</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2024.1392316</pub-id>, PMID: <pub-id pub-id-type="pmid">38711516</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Dorado</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Galan-Bartual</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hermoso</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Pneumococcal surface proteins: when the whole is greater than the sum of its parts</article-title>. <source>Mol. Oral. Microbiol.</source> <volume>27</volume>, <fpage>221</fpage>&#x2013;<lpage>245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.2041-1014.2012.00655.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22759309</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Riverol</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bandla</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kundu</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>KamatChinathan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hewapathirana</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>The PRIDE database at 20 years: 2025 update</article-title>. <source>Nucleic Acids Res.</source> <volume>53</volume>, <fpage>D543</fpage>&#x2013;<lpage>D553</lpage>., PMID: <pub-id pub-id-type="pmid">39494541</pub-id></citation></ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Riverol</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Q.-W.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Uszkoreit</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Griss</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sanchez</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>PRIDE inspector toolsuite: moving toward a universal visualization tool for proteomics data standard formats and quality assessment of proteomeXchange datasets</article-title>. <source>Mol. Cell. Proteomics MCP</source> <volume>15</volume>, <fpage>305</fpage>&#x2013;<lpage>317</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/mcp.O115.050229</pub-id>, PMID: <pub-id pub-id-type="pmid">26545397</pub-id></citation></ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pericone</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Overweg</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hermans</surname> <given-names>P. W.</given-names>
</name>
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract</article-title>. <source>Infection Immun.</source> <volume>68</volume>, <fpage>3990</fpage>&#x2013;<lpage>3997</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.68.7.3990-3997.2000</pub-id>, PMID: <pub-id pub-id-type="pmid">10858213</pub-id></citation></ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimentel</surname> <given-names>Z. T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Evolution of the natural transformation protein, comEC, in bacteria</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <elocation-id>2980</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.02980</pub-id>, PMID: <pub-id pub-id-type="pmid">30627116</pub-id></citation></ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plumptre</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Ogunniyi</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Paton</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Surface association of Pht proteins of Streptococcus pneumoniae</article-title>. <source>Infection Immun.</source> <volume>81</volume>, <fpage>3644</fpage>&#x2013;<lpage>3651</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00562-13</pub-id>, PMID: <pub-id pub-id-type="pmid">23876799</pub-id></citation></ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reder</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hentschker</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Steil</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gesell Salazar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dhople</surname> <given-names>V. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>MassSpecPreppy-An end-to-end solution for automated protein concentration determination and flexible sample digestion for proteomics applications</article-title>. <source>Proteomics</source> <volume>24</volume>, <elocation-id>e2300294</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pmic.202300294</pub-id>, PMID: <pub-id pub-id-type="pmid">37772677</pub-id></citation></ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigden</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Galperin</surname> <given-names>M. Y.</given-names>
</name>
<name>
<surname>Jedrzejas</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design</article-title>. <source>Crit. Rev. Biochem. Mol. Biol.</source> <volume>38</volume>, <fpage>143</fpage>&#x2013;<lpage>168</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/713609215</pub-id>, PMID: <pub-id pub-id-type="pmid">12749697</pub-id></citation></ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Rosario</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>M. D. L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Media matters, examining historical and modern streptococcus pneumoniae growth media and the experiments they affect</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>11</volume>, <elocation-id>613623</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.613623</pub-id>, PMID: <pub-id pub-id-type="pmid">33834003</pub-id></citation></ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gierok</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Petruschka</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lalk</surname> <given-names>M.</given-names>
</name>
<name>
<surname>M&#xe4;der</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Regulation of the arginine deiminase system by ArgR2 interferes with arginine metabolism and fitness of Streptococcus pneumoniae</article-title>. <source>mBio</source> <volume>5</volume> (<issue>6</issue>), pp.<fpage>10</fpage>-<lpage>1128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.01858-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25538192</pub-id></citation></ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates</article-title>. <source>Expert review of vaccines</source>, <volume>12</volume> (<issue>9</issue>), pp.<fpage>1061</fpage>-<lpage>1075</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/14760584.2013.824708</pub-id>, PMID: <pub-id pub-id-type="pmid">24053399</pub-id></citation></ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwanh&#xe4;usser</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Busse</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Dittmar</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Schuchhardt</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Global quantification of mammalian gene expression control</article-title>. <source>Nature</source> <volume>473</volume>, <fpage>337</fpage>&#x2013;<lpage>342</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature10098</pub-id>, PMID: <pub-id pub-id-type="pmid">21593866</pub-id></citation></ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seiberling</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bologa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brookes</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ochs</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Go</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Neveu</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults</article-title>. <source>Vaccine</source> <volume>30</volume>, <fpage>7455</fpage>&#x2013;<lpage>7460</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.10.080</pub-id>, PMID: <pub-id pub-id-type="pmid">23131206</pub-id></citation></ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sempere</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Llamos&#xed;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Del R&#xed;o Men&#xe9;ndez</surname> <given-names>I.</given-names>
</name>
<name>
<surname>L&#xf3;pez Ruiz</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Domenech</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Camacho</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pneumococcal choline-binding proteins involved in virulence as vaccine candidates</article-title>. <source>Vaccines</source> <volume>9</volume> (<issue>2</issue>), p.<fpage>181</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/vaccines9020181</pub-id>, PMID: <pub-id pub-id-type="pmid">33672701</pub-id></citation></ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafeeq</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kloosterman</surname> <given-names>T. G.</given-names>
</name>
<name>
<surname>Kuipers</surname> <given-names>O. P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Transcriptional response of Streptococcus pneumoniae to Zn2+) limitation and the repressor/activator function of AdcR</article-title>. <source>Metallomics integrated biometal Sci.</source> <volume>3</volume>, <fpage>609</fpage>&#x2013;<lpage>618</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c1mt00030f</pub-id>, PMID: <pub-id pub-id-type="pmid">21603707</pub-id></citation></ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simell</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Auranen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>K&#xe4;yhty</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Goldblatt</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dagan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>O'Brien</surname> <given-names>K. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The fundamental link between pneumococcal carriage and disease</article-title>. <source>Expert Rev. Vaccines</source> <volume>11</volume>, <fpage>841</fpage>&#x2013;<lpage>855</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/erv.12.53</pub-id>, PMID: <pub-id pub-id-type="pmid">22913260</pub-id></citation></ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strand</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Briles</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Gjessing</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Maage</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bhan</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Sommerfelt</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Pneumococcal pulmonary infection, septicaemia and survival in young zinc-depleted mice</article-title>. <source>Br. J. Nutr.</source> <volume>86</volume>, <fpage>301</fpage>&#x2013;<lpage>306</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1079/BJN2001399</pub-id>, PMID: <pub-id pub-id-type="pmid">11502245</pub-id></citation></ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strand</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Hollingshead</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Julshamn</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Briles</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Blomberg</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sommerfelt</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice</article-title>. <source>Infection Immun.</source> <volume>71</volume>, <fpage>2009</fpage>&#x2013;<lpage>2013</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.71.4.2009-2013.2003</pub-id>, PMID: <pub-id pub-id-type="pmid">12654820</pub-id></citation></ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mootha</surname> <given-names>V. K.</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ebert</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Gillette</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>102</volume> (<issue>43</issue>), pp.<fpage>15545</fpage>-<lpage>15550</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>, PMID: <pub-id pub-id-type="pmid">16199517</pub-id></citation></ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suomi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Elo</surname> <given-names>L. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Enhanced differential expression statistics for data-independent acquisition proteomics</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>5869</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-05949-y</pub-id>, PMID: <pub-id pub-id-type="pmid">28724900</pub-id></citation></ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname> <given-names>S. S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>32</volume>, <fpage>139</fpage>&#x2013;<lpage>153</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408410600822942</pub-id>, PMID: <pub-id pub-id-type="pmid">16893751</pub-id></citation></ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrasse</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Amoroso</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vernet</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Di Guilmi</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Streptococcus pneumoniae GAPDH is released by cell lysis and interacts with peptidoglycan</article-title>. <source>PloS&#xa0;One</source> <volume>10</volume>, <elocation-id>e0125377</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0125377</pub-id>, PMID: <pub-id pub-id-type="pmid">25927608</pub-id></citation></ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Beek</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Surmann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>van Berg Saparoea</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Houben</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Jong</surname> <given-names>W. S. P.</given-names>
</name>
<name>
<surname>Hentschker</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Exploring metal availability in the natural niche of Streptococcus pneumoniae to discover potential vaccine antigens</article-title>. <source>Virulence</source> <volume>11</volume>, <fpage>1310</fpage>&#x2013;<lpage>1328</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2020.1825908</pub-id>, PMID: <pub-id pub-id-type="pmid">33017224</pub-id></citation></ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vo&#xdf;</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Abdullah</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>van Opzeeland</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Saleh</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Intranasal vaccination with lipoproteins confers protection against pneumococcal colonisation</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02405</pub-id>, PMID: <pub-id pub-id-type="pmid">30405609</pub-id></citation></ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Paton</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Streptococcus pneumoniae: transmission, colonization and invasion</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>16</volume>, <fpage>355</fpage>&#x2013;<lpage>367</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-018-0001-8</pub-id>, PMID: <pub-id pub-id-type="pmid">29599457</pub-id></citation></ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiser</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Kapoor</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains</article-title>. <source>Infection Immun.</source> <volume>67</volume>, <fpage>3690</fpage>&#x2013;<lpage>3692</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.67.7.3690-3692.1999</pub-id>, PMID: <pub-id pub-id-type="pmid">10377162</pub-id></citation></ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weyder</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Prudhomme</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Berg&#xe9;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Polard</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Fichant</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dynamic modeling of Streptococcus pneumoniae competence provides regulatory mechanistic insights into its tight temporal regulation</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <elocation-id>1637</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.01637</pub-id>, PMID: <pub-id pub-id-type="pmid">30087661</pub-id></citation></ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkler</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Competence beyond genes: filling in the details of the pneumococcal competence transcriptome by a systems approach</article-title>. <source>J.&#xa0;hygiene</source> <volume>27</volume>, <fpage>113</fpage>&#x2013;<lpage>159</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00238-19</pub-id>, PMID: <pub-id pub-id-type="pmid">30988030</pub-id></citation></ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>K.-H.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.-H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Streptococcus pneumoniae diseases in Chinese children: past, present and future</article-title>. <source>Vaccine</source> <volume>26</volume>, <fpage>4425</fpage>&#x2013;<lpage>4433</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2008.06.052</pub-id>, PMID: <pub-id pub-id-type="pmid">18602435</pub-id></citation></ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>comCDE (Competence) operon is regulated by CcpA in Streptococcus pneumoniae D39</article-title>. <source>Microbiol. Spectr.</source> <volume>11</volume>, <elocation-id>e0001223</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.00012-23</pub-id>, PMID: <pub-id pub-id-type="pmid">37036382</pub-id></citation></ref>
</ref-list>
</back>
</article>